Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
43055225	li-fostau	ng/l (ng/l)	1604	1636	0.43%
43055225	li-fostau	— (—)	704	720	100.00%	Distribution not available
43055225	li-fosftau	ng/l (ng/l)	13	13	0.00%
43055225	li-fos-tau	— (—)	5	6	100.00%	Distribution not available
43055225	li-fosfo-tauproteiini,likvor	ng/l (ng/l)	5	5	0.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Psychiatric diseases

985

689

7.24

307.65

1.0

43.57

33.20

ng/l

7.63

683

480

Any dementia, excluding more controls

800

337

17.30

307.65

1.0

53.32

39.39

ng/l

5.94

584

202

Alzheimer’s disease, wide definition

555

272

17.96

307.65

1.0

57.86

39.48

ng/l

8.26

410

157

Unspecific neurodegenerative disorder

858

416

14.88

307.65

1.0

54.90

36.71

ng/l

13.52

610

244

Alzheimer’s disease (Late onset)

378

233

14.43

307.65

1.0

57.13

38.96

ng/l

6.01

271

129

Hydrocephalus

355

128

31.37

307.65

1.1

1.0

31.16

46.63

ng/l

2.86

101

Alzheimer’s disease (Early onset)

199

52.87

307.65

1.0

60.97

34.43

ng/l

4.14

151

Use of donepezil

411

291

14.27

307.65

1.0

59.71

42.81

ng/l

6.28

308

170

Use of anticholinesterases

685

419

13.86

307.65

1.0

55.85

39.26

ng/l

10.49

495

247

N06DA Anticholinesterases

685

419

13.86

307.65

1.0

55.85

39.26

ng/l

10.49

495

247

Normal-pressure hydrocephalus

330

47.23

307.65

1.1

1.0

31.46

50.22

ng/l

2.48

Alzheimer disease

617

345

14.09

307.65

1.0

57.80

40.57

ng/l

7.99

447

194

Any dementia

802

427

13.84

307.65

1.0

53.37

37.96

ng/l

9.11

586

246

Alzheimer’s disease, wide definition, excluding more controls

548

80.31

307.65

1.0

57.67

40.19

ng/l

3.12

405

Alzheimer disease, excluding more controls

599

68.33

307.65

1.0

57.52

38.21

ng/l

4.50

438

Organic, including symptomatic, mental disorders

1112

505

16.65

307.65

1.0

49.36

35.81

ng/l

10.84

782

325

Implicit Sepsis

838

1214

5.46

307.65

1.0

39.29

44.21

ng/l

1.17

659

780

Other degenerative diseases of the nervous system

757

180

33.63

307.65

1.0

53.04

40.25

ng/l

4.66

563

139

Dementia

908

374

17.56

307.65

1.0

52.48

36.93

ng/l

9.77

651

227

Dementia, including avohilmo

966

460

15.17

307.65

1.0

50.84

36.81

ng/l

9.47

697

278

Other mental disorders due to brain damage and dysfunction and to physical disease

357

131

29.56

307.65

1.0

43.77

36.28

ng/l

1.12

237

Other symptoms and signs involving cognitive functions and awareness

1277

504

25.18

307.65

1.0

42.37

44.90

ng/l

0.47

1041

273

Symptoms and signs involving cognition, perception, emotional state and behaviour

1402

824

12.19

307.65

1.0

42.29

39.50

ng/l

0.70

1097

468

Alzheimer disease, including avohilmo

707

390

13.67

307.65

1.0

56.69

38.98

ng/l

10.21

505

224

Any mental disorder

930

887

5.30

307.65

1.0

46.26

34.77

ng/l

4.55

656

599

Condition for Implicit Sepsis (Organ dysfunction codes)

1264

907

10.36

307.65

1.0

40.93

43.28

ng/l

0.50

1003

529

Degenerative diseases of the nervous system

764

404

14.94

307.65

1.0

53.60

39.61

ng/l

7.01

566

233

Alzheimer’s disease (Late onset), excluding more controls

371

62.18

307.65

1.0

56.82

42.16

ng/l

1.82

266

Dementia in Alzheimer disease

269

136

17.48

295.53

1.0

59.26

39.55

ng/l

3.55

166

Use of other anti-dementia drugs

362

341

9.53

282.77

1.0

60.50

42.51

ng/l

6.70

252

191

Use of memantine

362

341

9.53

282.77

1.0

60.50

42.51

ng/l

6.70

252

191

Use of rivastigmine

253

225

11.72

243.12

1.0

53.63

42.66

ng/l

2.31

185

133

Other neurological diseases

650

1332

3.97

208.86

1.0

37.74

44.05

ng/l

2.06

335

1012

Memory loss

172

107

16.86

204.18

1.0

41.48

36.71

ng/l

0.46

130

Depression or dysthymia

424

381

6.27

192.62

1.0

36.17

32.48

ng/l

0.90

290

257

Intracranial trauma

329

375

6.60

180.34

1.0

39.34

35.70

ng/l

0.59

212

295

Mood disorders, excluding more controls

572

857

4.09

173.50

1.0

35.74

34.46

ng/l

0.28

396

589

Neurological diseases

455

444

5.19

164.99

1.0

44.07

34.86

ng/l

3.43

313

347

Symptoms and signs involving the nervous and musculoskeletal systems

484

1283

3.82

157.22

1.0

39.16

42.89

ng/l

0.35

302

905

Unspecified dementia

140

15.80

152.00

1.0

49.07

41.01

ng/l

0.62

109

Circumscribed brain atrophy

38.19

148.07

1.0

37.36

26.12

ng/l

1.58

Dizziness and giddiness

390

749

4.26

138.50

1.0

41.78

41.23

ng/l

0.07

251

420

Concussion

251

365

5.99

134.06

1.0

40.89

35.48

ng/l

0.85

168

286

Other antidepressants

647

1152

2.95

115.98

1.0

40.56

43.32

ng/l

0.52

430

829

Recurrent or chronic depression

201

220

6.64

109.31

1.0

33.59

33.81

ng/l

0.02

130

152

Parkinson's disease, excluding more controls

101

14.08

108.50

1.0

34.90

35.42

ng/l

0.04

Undefined dementia

140

163

8.08

99.56

1.0

49.07

45.26

ng/l

0.34

109

Other and unspecified degenerative diseases of nervous system

26.82

98.96

1.1

41.35

30.61

ng/l

0.95

Parkinson's disease, strict definition, excluding more controls

14.16

98.42

1.1

1.0

33.63

34.41

ng/l

0.07

Other symptoms and signs involving the nervous and musculoskeletal systems

311

873

3.60

93.18

1.0

36.83

44.07

ng/l

2.46

200

612

Abnormalities of gait and mobility

151

237

6.55

92.02

1.1

1.0

43.96

45.61

ng/l

0.03

150

Medical observation and evaluation for suspected diseases and conditions

414

667

3.20

84.19

1.0

40.89

41.86

ng/l

0.14

241

518

Delirium, not induced by alcohol and other psychoactive substances

102

116

8.96

82.01

1.0

37.67

37.59

ng/l

0.01

Anxiety disorders, excluding more controls

365

775

3.14

78.95

1.0

35.29

34.70

ng/l

0.10

276

539

Implicit bacterial Sepsis

273

719

3.52

77.29

1.0

38.59

46.57

ng/l

2.77

209

452

Selective serotonin reuptake inhibitors

549

1152

2.52

74.62

1.0

42.04

43.32

ng/l

0.18

361

829

Alzheimer’s disease (Atypical or mixed)

9.25

72.40

1.0

1.1

53.97

35.85

ng/l

1.58

Mood [affective] disorders

575

1633

2.33

70.44

1.0

35.80

43.09

ng/l

2.95

399

1164

Mood disorders

574

1635

2.32

69.61

1.0

35.66

43.18

ng/l

3.11

398

1166

Schizophrenia or delusion, excluding more controls

151

317

4.76

66.14

1.0

50.99

35.94

ng/l

0.62

115

215

Depression

525

1563

2.32

64.92

1.0

35.18

43.36

ng/l

3.96

361

1122

Bacterial Sepsis

276

795

3.11

64.07

1.0

38.73

46.20

ng/l

2.60

211

497

Use of galantamine

114

7.86

62.61

1.1

1.0

56.28

42.76

ng/l

1.48

Viral Sepsis

148

324

4.63

62.53

1.1

1.0

36.47

49.35

ng/l

3.07

104

200

Implicit viral Sepsis

146

323

4.58

60.89

1.1

1.0

36.59

49.38

ng/l

3.00

103

199

Vascular dementia

9.44

59.41

1.0

47.78

34.03

ng/l

1.60

Extrapyramidal and movement disorders

260

881

2.98

57.53

1.0

36.60

43.99

ng/l

1.70

170

595

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

151

141

5.39

57.17

1.0

40.56

41.59

ng/l

0.08

100

Dementia in other diseases classified elsewhere

10.89

54.37

1.0

37.22

41.57

ng/l

0.20

Other and unspecified hydrocephalus

16.24

54.17

1.1

1.0

29.00

39.06

ng/l

0.60

Frontotemporal dementia, wide, incl. Pick's disease

33.38

51.34

1.0

1.1

39.21

29.86

ng/l

—

Vascular dementia (subcortical)

17.73

49.91

1.1

1.0

54.17

27.39

ng/l

—

Nonorganic sleeping disorders, excluding more controls

145

6.05

49.84

1.0

32.20

37.46

ng/l

0.55

Neurological diseases, wide definition

116

6.15

49.41

1.0

41.33

32.54

ng/l

0.88

General examination and investigation of persons without complaint and reported diagnosis

326

667

2.61

48.02

1.0

36.83

41.86

ng/l

1.41

213

518

Substance abuse, excluding more controls

227

683

2.92

47.36

1.0

40.44

34.54

ng/l

1.57

167

470

Malaise and fatigue

288

939

2.57

46.51

1.0

40.56

44.56

ng/l

0.80

197

649

Epilepsy

188

598

3.16

46.22

1.0

36.98

42.45

ng/l

1.33

137

420

Traumatic subdural haemorrhage

108

6.72

45.95

1.0

37.02

42.62

ng/l

0.49

Postprocedural disorders of nervous system

7.79

44.65

1.0

54.32

40.74

ng/l

0.81

Injuries to the head

535

1776

1.97

43.33

1.0

38.63

42.59

ng/l

1.05

367

1251

Benzodiazepine use

503

1815

1.98

42.19

1.0

39.34

42.36

ng/l

0.77

358

1262

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

227

4.34

38.62

1.0

37.71

36.31

ng/l

0.08

158

Psychotic depression

13.01

37.45

1.0

28.60

40.00

ng/l

0.87

Depression medications

136

173

3.97

37.37

1.0

40.12

42.30

ng/l

0.18

132

Bipolar affective disorders

106

270

3.96

36.88

1.0

35.01

45.59

ng/l

1.07

203

Intracranial injury

287

1235

2.26

36.03

1.0

39.67

42.97

ng/l

0.51

185

840

Unspecified mental disorder

215

845

2.56

35.93

1.0

44.43

41.38

ng/l

0.13

156

590

Kela-code for severe mental illness

199

763

2.62

35.03

1.0

45.39

41.05

ng/l

0.17

142

538

Personality disorders, excluding more controls

219

4.18

34.18

1.0

31.83

36.01

ng/l

0.59

155

Other special examinations and investigations of persons without complaint or reported diagnosis

301

667

2.29

33.56

1.0

41.46

41.86

ng/l

0.05

203

518

Other extrapyramidal and movement disorders in other diseases

151

517

2.95

33.09

1.0

40.30

45.79

ng/l

0.59

102

355

Fall on same level

532

1649

1.81

32.33

1.0

46.33

40.12

ng/l

0.83

368

1175

Convulsions, not elsewhere classified

133

425

3.11

32.02

1.0

37.03

43.75

ng/l

1.22

302

Persons encountering health services for examination and investigation

298

667

2.25

31.74

1.0

43.03

41.86

ng/l

0.15

198

518

Examination and observation for other reasons

252

665

2.31

30.30

1.0

37.67

41.86

ng/l

1.00

161

518

Focal epilepsy

129

437

2.98

28.83

1.0

37.78

43.42

ng/l

0.95

296

Use of levodopa decarboxylase inhibitor

105

320

3.33

28.17

1.0

32.15

46.32

ng/l

4.19

201

Other degenerative diseases of the basal ganglia

9.53

28.01

1.1

1.0

34.47

42.00

ng/l

0.53

Anxiety (asthma-related co-morbidities)

236

841

2.22

27.58

1.0

35.71

41.09

ng/l

1.26

175

608

General symptoms and signs

487

1379

1.77

27.25

1.0

38.48

42.83

ng/l

1.14

324

997

Episodal and paroxysmal disorders

473

1366

1.78

26.86

1.0

40.63

43.73

ng/l

0.64

316

966

Communicating hydrocephalus

9.50

26.66

1.2

1.0

34.82

39.90

ng/l

0.16

Other anxiety disorders

179

653

2.44

26.63

1.0

37.27

41.36

ng/l

0.68

129

464

Focal epilepsy, mode (most common among epilepsy diagnosis)

116

389

3.01

26.46

1.0

37.46

44.58

ng/l

1.28

264

Syncope and collapse

226

928

2.17

25.52

1.0

37.05

43.91

ng/l

2.06

143

647

Focal epilepsy, strict definition

118

410

2.90

25.28

1.0

38.30

43.86

ng/l

0.87

276

Other symptoms and signs involving general sensations and perceptions

9.84

25.05

1.0

38.59

32.50

ng/l

—

STROKE

335

1230

1.90

25.03

1.0

36.24

43.76

ng/l

2.36

233

886

Behavioural syndromes associated with physiological disturbances and physical factors

134

500

2.69

25.02

1.0

33.48

43.52

ng/l

2.77

352

Non-selective monoamine reuptake inhibitors

187

794

2.30

24.71

1.0

35.49

45.96

ng/l

2.33

125

578

Cerebrovascular diseases

388

1558

1.79

24.34

1.0

38.35

43.73

ng/l

1.53

257

1081

Parkinson's disease, including avohilmo

112

388

2.92

24.20

1.0

34.38

45.36

ng/l

2.89

252

Sleep disorders

107

374

2.88

22.72

1.0

33.91

43.47

ng/l

2.01

265

Other disorders of urethra and urinary system

317

1282

1.86

22.68

1.0

37.40

43.15

ng/l

2.01

212

884

Schizophrenia, schizotypal and delusional disorders

153

643

2.39

22.39

1.0

50.85

40.52

ng/l

0.38

116

454

Other and unspecified nonorganic psychotic disorders

300

3.09

22.09

1.0

60.25

43.16

ng/l

0.39

207

Metabolic disorders

446

1650

1.68

21.99

1.0

36.17

43.52

ng/l

2.71

321

1146

Headache

271

1182

1.92

21.95

1.0

37.74

43.26

ng/l

1.24

182

861

Schizophrenia or delusion

151

637

2.38

21.92

1.0

50.99

40.49

ng/l

0.39

115

451

Hypothyroidism (congenital or acquired)

171

3.20

20.72

1.0

39.81

42.52

ng/l

0.18

131

All anxiety disorders

236

970

1.96

20.28

1.0

35.71

42.95

ng/l

1.49

175

689

Hypothyroidism and >3 levothyroxin purchases

171

3.17

20.23

1.0

40.19

42.52

ng/l

0.15

131

Hypothyroidism, levothyroxine purchases

171

3.17

20.23

1.0

40.19

42.52

ng/l

0.15

131

Parkinson's disease

101

373

2.74

19.47

1.0

34.90

46.03

ng/l

2.71

240

Progressive vascular leukoencephalopathy

6.43

19.35

1.0

34.09

42.76

ng/l

0.66

Sleep disorders (combined)

435

1751

1.63

19.35

1.0

37.33

42.99

ng/l

1.99

297

1231

Disorders of lipoprotein metabolism and other lipidaemias

417

1592

1.65

19.25

1.0

37.05

43.73

ng/l

2.18

306

1104

Infections, IBD-co-morbidities

4.42

19.09

1.0

39.04

33.54

ng/l

0.48

Anxiety disorders

367

1584

1.65

17.21

1.0

35.13

42.35

ng/l

2.58

278

1108

Parkinson's disease, strict definition

341

2.70

17.11

1.1

1.0

33.63

45.95

ng/l

2.90

217

Manic episode

7.63

17.00

1.0

51.71

44.17

ng/l

0.11

Neurotic, stress-related and somatoform disorders

361

1567

1.64

16.78

1.0

35.03

42.32

ng/l

2.59

272

1095

Constipation

392

1758

1.60

16.50

1.0

46.06

41.65

ng/l

0.37

272

1228

Abnormal involuntary movements

264

2.91

16.48

1.0

32.60

46.13

ng/l

2.21

180

Nonorganic sleeping disorders

325

2.69

16.44

1.0

32.20

43.25

ng/l

2.17

227

Pure hypercholesterolaemia

368

1522

1.63

16.34

1.0

36.27

44.55

ng/l

3.17

268

1044

Spondylopathies

357

1320

1.65

16.30

1.0

35.58

43.33

ng/l

3.70

221

966

Sequelae of injuries of head

100

4.27

16.25

1.0

36.23

39.16

ng/l

0.15

Dorsalgia

394

1328

1.61

16.07

1.0

37.49

43.23

ng/l

2.02

248

970

Other intervertebral disc disorders

353

1326

1.63

15.67

1.0

42.90

43.27

ng/l

0.02

235

969

Lower back pain or/and sciatica

423

1894

1.55

15.58

1.0

36.17

42.75

ng/l

2.50

260

1361

Other dorsopathies, not elsewhere classified

400

1328

1.59

15.52

1.0

38.73

43.23

ng/l

1.21

250

970

Cerebrovascular diseases (FINNGEN)

183

669

1.97

15.52

1.0

34.94

44.32

ng/l

3.06

132

501

Open wound of head

214

1163

1.82

15.20

1.0

39.49

42.50

ng/l

0.55

151

800

Schizoaffective disorder

133

3.65

15.07

1.0

37.63

45.16

ng/l

0.28

severe traumatic brain injury, does not include concussion

113

502

2.27

14.76

1.0

32.83

43.66

ng/l

2.18

327

Follow-up examination after treatment for conditions other than malignant neoplasms

160

517

2.03

14.65

1.0

34.92

43.33

ng/l

2.39

116

407

Insomnia

271

2.75

14.58

1.0

34.51

45.72

ng/l

1.92

189

Focal brain injury

5.43

14.47

1.0

22.39

37.82

ng/l

1.88

Other disorders of ear

412

1790

1.54

14.45

1.0

45.96

41.00

ng/l

0.45

280

1268

Generalized anxiety disorder

162

3.29

14.31

1.0

40.32

45.39

ng/l

0.34

107

Factors influencing health status and contact with health services

139

329

2.13

13.37

1.0

46.51

43.92

ng/l

0.21

260

Falls/tendency to fall

429

1420

1.52

13.36

1.0

40.27

40.08

ng/l

0.03

297

1011

Statin medication

264

878

1.69

13.19

1.0

38.11

42.87

ng/l

0.84

180

645

Monoamine oxidase A inhibitors

203

2.93

13.10

1.1

1.0

38.97

45.58

ng/l

0.50

149

Disorders of thyroid, IBD co-morbidities

3.66

13.07

1.0

39.20

30.74

ng/l

0.81

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

1180

0.38

12.83

1.0

34.49

44.70

ng/l

1.59

790

Viral infections of the central nervous system

119

3.57

12.81

1.0

40.06

43.59

ng/l

0.17

Care involving use of rehabilitation procedures

283

1682

1.60

12.65

1.0

34.71

42.83

ng/l

3.09

229

1151

Dorsopathies

395

1329

1.52

12.55

1.0

38.42

43.20

ng/l

1.31

248

971

Speech disturbances, not elsewhere classified

177

3.03

12.44

1.0

33.65

45.36

ng/l

1.73

104

Other diseases of intestines

414

1616

1.49

12.40

1.0

37.48

41.97

ng/l

1.16

291

1133

Low back pain

277

1325

1.61

12.38

1.0

35.20

43.24

ng/l

3.32

180

969

Pain in throat and chest

342

1355

1.55

12.21

1.0

36.20

43.79

ng/l

2.61

248

936

Viral encephalitis, not elsewhere classified/unspecified

6.15

12.18

1.0

45.04

40.04

ng/l

0.15

Sciatica+with lumbago

213

1192

1.70

12.09

1.0

36.05

42.85

ng/l

1.72

124

880

Shoulder lesions

347

1393

1.53

11.81

1.0

37.84

42.86

ng/l

1.31

243

973

Other encephalitis

5.60

11.68

1.0

43.44

33.30

ng/l

0.60

Other reaction to severe stress, and adjustment disorders

124

627

1.98

11.66

1.0

31.95

41.28

ng/l

2.49

447

Parasetamol

299

961

1.59

11.65

1.0

39.31

40.57

ng/l

0.21

199

729

Abnormal findings on diagnostic imaging of central nervous system

4.01

11.49

1.1

1.0

29.70

44.27

ng/l

1.34

Alcohol abuse, main dg, excluding more controls

165

2.98

11.33

1.0

38.02

34.06

ng/l

0.32

110

Sequelae of cerebrovascular disease

157

756

1.83

11.32

1.0

37.96

44.90

ng/l

1.35

111

498

Poisoning by medicine

364

2.29

11.29

1.0

31.89

44.31

ng/l

2.97

258

Poisoning by drugs, medicaments and biological substances

409

2.21

11.24

1.0

32.44

44.28

ng/l

2.98

289

Degeneration of the brain due to alcohol

5.65

11.22

1.0

1.1

48.19

35.86

ng/l

0.70

Somnolence, stupor and coma

5.58

11.18

1.0

1.1

27.35

37.51

ng/l

0.69

Conductive and sensorineural hearing loss

359

1676

1.49

11.00

1.0

47.55

41.89

ng/l

0.45

242

1171

Lumbar disc prolapse

260

1309

1.58

10.84

1.0

45.60

43.18

ng/l

0.11

169

963

Encephalitis

5.20

10.82

1.0

43.44

30.76

ng/l

0.83

Other headache syndromes

157

880

1.79

10.79

1.0

36.50

44.52

ng/l

1.50

101

625

Persons encountering health services for specific procedures and health care

417

1802

1.44

10.51

1.0

38.13

42.60

ng/l

1.34

313

1241

247

1408

1.58

10.32

1.0

41.09

40.67

ng/l

0.06

177

982

Transient ischemic attack

236

1230

1.60

10.27

1.0

37.34

43.67

ng/l

1.95

162

817

Symptoms and signs involving speech and voice

142

785

1.82

10.26

1.0

52.33

43.22

ng/l

0.33

113

527

Persistent mood disorders

354

2.24

10.26

1.0

38.94

46.45

ng/l

1.04

254

Other diseases of urinary system

400

1560

1.45

10.26

1.0

39.31

42.23

ng/l

0.73

277

1088

Disorders of adult personality and behaviour

472

2.06

10.21

1.0

37.69

42.65

ng/l

0.34

342

Dysphagia

116

605

1.93

10.07

1.0

37.93

43.32

ng/l

0.93

399

234

1361

1.58

10.03

1.0

41.35

40.26

ng/l

0.17

170

948

Alcohol use disorder, Swedish definition

227

1331

1.59

9.88

1.0

41.06

40.04

ng/l

0.16

162

934

Sensorineural hearing loss

339

1622

1.47

9.78

1.0

47.96

42.17

ng/l

0.43

227

1131

Mental and behavioural disorders due to psychoactive substance use

235

1417

1.57

9.76

1.0

40.23

40.41

ng/l

0.03

174

995

Cervicalgia

434

2.08

9.74

1.0

37.73

44.90

ng/l

0.97

317

Superficial injury of head

421

2.10

9.72

1.0

34.49

45.54

ng/l

2.23

289

Other sleep disorders

221

2.55

9.68

1.0

41.52

44.16

ng/l

0.22

157

Mental and behavioural disorders due to alcohol

208

1268

1.60

9.47

1.0

41.42

40.14

ng/l

0.19

152

890

Traumatic subarachnoid haemorrhage

6.21

9.47

1.1

1.0

23.64

36.68

ng/l

1.53

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

1220

0.45

9.41

1.0

38.68

44.98

ng/l

0.69

819

Secondary parkinsonism+Parkinsonism in other disease

4.42

9.37

1.0

31.56

49.44

ng/l

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

495

1.99

9.35

1.0

37.71

42.73

ng/l

0.36

355

Malignant neoplasm of digestive organs

1054

0.38

9.34

1.0

35.82

44.04

ng/l

1.07

693

Anaemias

171

2.46

9.23

1.0

38.82

42.52

ng/l

0.30

131

Use of hypnotics and sedatives

425

1761

1.40

9.18

1.0

43.15

41.52

ng/l

0.13

309

1221

Hyperplasia of prostate

185

634

1.67

9.06

1.0

39.83

40.80

ng/l

0.12

132

425

Substance abuse

227

1403

1.55

9.00

1.0

40.44

40.24

ng/l

0.03

167

986

Other soft tissue disorders, not elsewhere classified

329

1400

1.45

8.96

1.0

37.80

42.82

ng/l

1.13

229

976

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

728

0.27

8.88

1.0

37.00

44.46

ng/l

0.33

483

Nerve, nerve root and plexus disorders

414

1881

1.38

8.64

1.0

40.51

41.96

ng/l

0.26

298

1305

Cerebral cysts

3.75

8.62

1.0

36.83

44.34

ng/l

0.38

Spinal stenosis

225

1144

1.55

8.57

1.0

35.00

44.90

ng/l

4.29

135

831

Stroke, including SAH

273

1365

1.48

8.51

1.0

37.84

42.65

ng/l

1.20

176

927

Non-invasive ventilation

423

1.98

8.42

1.1

1.0

30.55

44.41

ng/l

4.43

303

Hypertension, essential

322

1273

1.45

8.42

1.0

36.75

42.46

ng/l

1.71

235

906

Personality disorders

466

1.96

8.40

1.0

31.83

42.71

ng/l

3.06

334

Diseases of oesophagus, stomach and duodenum

412

1816

1.38

8.39

1.0

39.90

42.14

ng/l

0.47

303

1258

Persistent delusional disorders

155

2.73

8.34

1.0

42.34

42.73

ng/l

0.02

Mental and behavioural disorders due to alcohol, excluding acute intoxication

185

1164

1.59

8.33

1.0

41.84

39.98

ng/l

0.28

135

826

Other functional intestinal disorders

178

1056

1.61

8.33

1.0

41.76

44.85

ng/l

0.28

125

715

Secondary parkinsonism

4.15

8.29

1.0

33.38

45.11

ng/l

—

Suicide or other Intentional self-harm

477

1.94

8.21

1.0

38.38

43.23

ng/l

0.31

341

Sleep apnoea

367

1792

1.39

8.02

1.0

38.36

42.35

ng/l

1.07

252

1264

Migraine without aura

225

2.36

7.89

1.0

35.65

43.01

ng/l

0.64

161

Heart failure and coronary heart disease

694

0.40

7.73

1.0

44.68

44.48

ng/l

0.01

444

Symptoms and signs involving the urinary system

309

1690

1.42

7.66

1.0

43.09

42.56

ng/l

0.08

220

1155

Sleep apnoea, including avohilmo

381

1804

1.37

7.65

1.0

37.96

42.48

ng/l

1.32

260

1272

Disturbances of smell and taste

4.76

7.64

1.1

36.22

37.84

ng/l

—

Unspecified fall

178

1126

1.57

7.64

1.0

46.89

42.14

ng/l

0.18

129

761

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

663

0.35

7.63

1.0

33.87

45.22

ng/l

2.27

429

Diseases of the ear and mastoid process

436

1639

1.35

7.46

1.0

45.60

40.21

ng/l

0.55

301

1159

Hypertensive diseases (excluding secondary)

201

755

1.55

7.44

1.0

36.87

42.96

ng/l

1.13

144

566

Other external causes of accidental injury

308

1084

1.43

7.34

1.0

41.15

40.92

ng/l

0.03

220

740

Degeneration of nervous system due to alcohol

3.90

7.29

1.0

48.19

39.07

ng/l

0.51

Other lack of coordination

5.49

7.28

1.2

1.0

34.20

31.15

ng/l

—

Pain in limb

276

1395

1.43

7.27

1.0

35.46

42.85

ng/l

2.24

193

974

Alcohol use disorder, ICD-based

168

1073

1.57

7.21

1.0

41.71

39.98

ng/l

0.25

122

753

Colorectal cancer, excluding all cancers (controls excluding all cancers)

840

0.40

7.21

1.0

37.25

44.89

ng/l

0.67

550

Restless leg syndrome

274

2.17

7.17

1.0

36.60

46.91

ng/l

1.84

174

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

128

2.75

7.09

1.1

1.0

36.52

45.88

ng/l

0.88

Injuries to the thorax

170

1095

1.56

7.03

1.0

36.23

42.43

ng/l

1.71

114

754

Stroke, excluding SAH

251

1292

1.45

6.99

1.0

37.92

42.72

ng/l

1.17

163

876

Persons encountering health services in other circumstances, wide

454

1785

1.32

6.88

1.0

34.40

43.96

ng/l

5.64

345

1214

Hypertensive diseases

314

1276

1.39

6.83

1.0

36.47

42.41

ng/l

1.88

229

908

Hypertension

314

1276

1.39

6.82

1.0

36.47

42.41

ng/l

1.88

229

908

Covid-19 confirmed case

103

590

1.75

6.77

1.1

1.0

41.65

43.63

ng/l

0.21

392

Mixed and other personality disorders

126

2.72

6.76

1.0

30.09

39.56

ng/l

1.02

Cardiodefibrillation

1104

0.49

6.75

1.0

33.84

42.57

ng/l

1.82

740

Bleeding

335

1786

1.37

6.74

1.0

39.31

42.88

ng/l

0.58

219

1254

Diseases of male genital organs

207

693

1.51

6.73

1.0

36.22

39.52

ng/l

0.64

153

472

Spondylosis

217

1276

1.46

6.56

1.0

36.23

43.74

ng/l

2.26

130

937

Rotator cuff syndrome

262

1377

1.42

6.54

1.0

36.92

43.09

ng/l

1.56

184

962

Type 2 diabetes, wide definition

339

1627

1.36

6.52

1.0

36.52

43.44

ng/l

2.39

234

1149

Pain (limb, back, neck, head abdominally)

282

1002

1.41

6.45

1.0

40.73

42.51

ng/l

0.28

189

718

Transient global amnesia

141

2.57

6.44

1.0

50.96

34.27

ng/l

0.94

Inflammatory diseases of the central nervous system

171

2.41

6.43

1.1

1.0

40.78

43.41

ng/l

0.16

106

Any gastric operation

286

1021

1.41

6.43

1.0

41.22

41.71

ng/l

0.06

183

791

GASTRO-related operations

286

1021

1.41

6.43

1.0

41.22

41.71

ng/l

0.06

183

791

Provisional assignment of new diseases of uncertain etiology

143

906

1.58

6.40

1.0

38.86

41.09

ng/l

0.32

110

613

Codes for special purposes

143

907

1.58

6.37

1.0

38.86

41.06

ng/l

0.32

110

614

Dental operations

269

976

1.42

6.31

1.0

45.46

39.65

ng/l

1.09

175

667

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

262

2.11

6.30

1.0

33.85

42.55

ng/l

1.21

183

Endocrine, nutritional and metabolic diseases

278

1006

1.41

6.30

1.0

37.61

45.35

ng/l

1.84

195

723

Hypotension

345

1.95

6.22

1.0

39.18

43.87

ng/l

0.43

211

Phobic anxiety disorders

126

2.63

6.20

1.0

36.43

44.68

ng/l

0.43

Heart failure, strict

117

1356

0.62

6.17

1.0

35.88

43.37

ng/l

2.13

897

Accidents

299

1084

1.38

6.11

1.0

40.54

40.92

ng/l

0.06

218

740

Heart failure,strict

109

1284

0.61

6.11

1.0

35.99

42.55

ng/l

1.63

871

Soft tissue disorders

361

1401

1.34

6.09

1.0

40.04

42.79

ng/l

0.48

245

977

Cervical disc disorders

150

975

1.54

6.04

1.0

37.30

43.26

ng/l

1.44

103

721

Migraine

135

727

1.58

5.95

1.0

33.53

44.19

ng/l

2.00

527

Specific personality disorders

388

1.86

5.85

1.0

41.07

43.89

ng/l

0.13

277

251

2.08

5.80

1.0

32.07

49.20

ng/l

4.17

164

All-cause Heart Failure

117

1334

0.63

5.75

1.0

36.62

43.39

ng/l

1.74

878

COPD, hospital admissions 1, only main diagnosis

857

0.51

5.73

1.0

47.71

43.48

ng/l

0.28

565

Other and unspecified polyneuropathies, also in other diseases

493

1.75

5.73

1.0

57.33

43.68

ng/l

0.25

324

Fever of other and unknown origin

178

1123

1.47

5.71

1.0

37.32

44.40

ng/l

1.57

113

796

Fracture of rib(s), sternum and thoracic spine

118

736

1.61

5.71

1.0

37.05

42.84

ng/l

1.09

497

Dementia due to Parkinson's disease

3.76

5.67

1.1

35.25

39.80

ng/l

0.21

COPD, hospital admissions

1186

0.58

5.63

1.0

39.12

43.53

ng/l

0.48

785

Parodontitis and operation codes

334

1965

1.32

5.58

1.0

39.31

42.15

ng/l

0.63

237

1378

Diabetes medication

376

1750

1.31

5.55

1.0

36.42

42.88

ng/l

2.15

262

1236

Dental operations, only avohilmo

278

1038

1.37

5.53

1.0

43.05

40.18

ng/l

0.46

184

711

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

574

0.36

5.51

1.0

34.87

45.29

ng/l

0.95

366

COPD, early/later onset

1196

0.59

5.49

1.0

38.84

43.45

ng/l

0.53

794

Other CVD (FINNGEN)

242

1.96

5.47

1.1

1.0

39.18

48.91

ng/l

1.06

163

External causes of morbidity and mortality

243

869

1.40

5.45

1.0

43.83

41.27

ng/l

0.42

171

593

Fracture of skull and facial bones

435

1.78

5.41

1.0

31.52

42.73

ng/l

2.62

303

COPD, hospital admissions 3, with asthma pneumonia sepsis

631

0.44

5.40

1.1

1.0

37.69

43.86

ng/l

0.47

404

Dental pulpitis 2, only avohilmo

287

1081

1.36

5.39

1.0

46.47

42.52

ng/l

0.57

195

740

Sequelae of injuries, of poisoning and of other consequences of external causes

540

1.69

5.38

1.0

37.75

42.29

ng/l

0.57

379

Dental caries, including avohilmo

308

1173

1.34

5.35

1.0

44.21

42.68

ng/l

0.19

210

804

COPD related to multimorbidity

991

0.56

5.34

1.0

33.51

44.14

ng/l

1.89

652

Dental caries 1

308

1174

1.34

5.32

1.0

44.21

42.65

ng/l

0.19

210

805

Ischaemic Stroke, excluding all haemorrhages

226

1227

1.40

5.30

1.0

36.78

43.14

ng/l

1.70

148

815

Dental caries 1, only avohilmo

312

1194

1.34

5.27

1.0

42.79

42.78

ng/l

0.00

212

819

Genitourinary diseases

221

783

1.42

5.26

1.0

41.40

41.25

ng/l

0.02

152

549

Parodontitis or operation codes

347

1960

1.31

5.26

1.0

39.05

42.23

ng/l

0.75

243

1374

Dental caries 3, only avohilmo

323

1243

1.33

5.26

1.0

42.66

42.46

ng/l

0.02

220

855

Alcohol dependence

110

692

1.59

5.18

1.0

40.90

41.16

ng/l

0.03

479

Parodontitis

346

1961

1.30

5.16

1.0

39.05

42.23

ng/l

0.75

243

1374

Hypothyroidism, strict autoimmune, 3 medication purchases required

297

1524

1.33

5.11

1.0

38.79

43.61

ng/l

0.79

186

1075

Colorectal cancer

639

0.42

5.10

1.0

38.11

43.88

ng/l

0.43

414

Later onset COPD

613

0.47

5.10

1.1

1.0

33.29

44.77

ng/l

1.54

373

Influenza and pneumonia

369

1883

1.29

5.04

1.0

40.04

41.98

ng/l

0.14

255

1332

Acute and transient psychotic disorders

219

2.06

4.96

1.0

45.18

45.46

ng/l

0.01

144

Injuries to the shoulder and upper arm

303

1935

1.31

4.95

1.0

47.46

41.18

ng/l

0.42

211

1348

Other chronic obstructive pulmonary disease

1144

0.61

4.93

1.0

38.84

43.51

ng/l

0.54

757

Chronic periodontitis, including avohilmo

343

1963

1.29

4.92

1.0

39.01

42.21

ng/l

0.74

240

1376

COPD, hospital admission 2, with asthma infections

768

0.52

4.89

1.0

40.18

43.30

ng/l

0.19

502

Diseases of the musculoskeletal system and connective tissue

172

591

1.46

4.87

1.0

40.81

43.33

ng/l

0.29

109

426

Cervicocranial syndrome

221

2.05

4.86

1.0

32.19

47.93

ng/l

1.84

159

Migraine without aura and triptan purchases

181

2.16

4.85

1.0

34.88

43.39

ng/l

0.81

128

Migraine with aura

340

1.83

4.84

1.0

27.81

42.52

ng/l

4.63

240

Dental pulpitis 2

277

1062

1.34

4.72

1.0

47.44

42.74

ng/l

0.69

185

723

Disorders of lens

300

1442

1.31

4.71

1.0

41.33

43.52

ng/l

0.33

207

1029

Oter anti-inflammatory and antirheumatic agents, non-steroids

311

1.66

4.71

1.0

34.44

44.83

ng/l

2.01

217

Colorectal adenocarcinoma

531

0.39

4.69

1.0

34.88

43.78

ng/l

0.77

345

Exposure to unspecified factor

330

1987

1.29

4.67

1.0

38.91

42.16

ng/l

0.73

257

1364

Cystitis

286

1325

1.32

4.64

1.0

46.13

43.24

ng/l

0.16

202

911

All influenza

563

1.62

4.63

1.0

32.52

44.46

ng/l

3.22

391

Symptoms and signs concerning food and fluid intake

178

2.14

4.63

1.1

1.0

58.62

44.53

ng/l

0.40

120

Diabetes mellitus

367

1716

1.28

4.63

1.0

35.37

43.09

ng/l

3.02

256

1210

Cardiovascular diseases (excluding rheumatic etc)

186

759

1.42

4.62

1.0

38.95

42.91

ng/l

0.64

121

568

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

356

1.78

4.61

1.0

66.81

43.95

ng/l

0.33

247

Symptoms and signs involving the digestive system and abdomen

371

1454

1.28

4.60

1.0

41.34

41.83

ng/l

0.07

257

1018

Visual disturbances and blindness

173

1228

1.41

4.58

1.0

38.22

43.93

ng/l

1.08

122

828

Anomalies of pupillary function

4.45

4.57

1.0

23.83

46.21

ng/l

—

Dental caries 3

312

1222

1.31

4.54

1.0

44.40

42.36

ng/l

0.27

213

840

Other problems related to primary support group, including family circumstances

119

2.38

4.52

1.0

94.29

45.70

ng/l

0.37

COPD

1180

0.63

4.51

1.0

37.61

42.97

ng/l

0.72

787

Abnormalities of breathing

298

1355

1.31

4.51

1.0

34.51

43.79

ng/l

3.21

208

936

Diseases of the myoneural junction and muscle

284

1.88

4.49

1.0

33.92

44.83

ng/l

1.53

188

Transport accidents

145

885

1.45

4.47

1.0

37.14

40.44

ng/l

0.49

103

600

Dystonia

105

2.49

4.46

1.1

1.0

30.96

50.66

ng/l

2.60

Diabetes, varying definitions

365

1718

1.27

4.43

1.0

35.35

43.09

ng/l

3.02

255

1211

Hypothyroidism, strict autoimmune

266

1334

1.32

4.42

1.0

39.16

44.27

ng/l

0.74

167

932

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

555

0.43

4.35

1.0

41.43

45.50

ng/l

0.17

354

Dental caries 3 and operation codes

336

1343

1.29

4.34

1.0

44.30

42.29

ng/l

0.27

231

924

Hard cardiovascular diseases

333

1673

1.28

4.32

1.0

36.34

43.19

ng/l

2.29

221

1190

Status epilepticus

2.98

4.29

1.0

38.00

43.39

ng/l

0.20

Continuous positive airway pressure

381

1.68

4.27

1.0

50.00

44.10

ng/l

0.58

276

Symptoms and signs involving the circulatory and respiratory systems

345

1355

1.28

4.25

1.0

36.69

43.79

ng/l

2.01

246

936

Oxycodone

1050

0.60

4.23

1.0

34.83

44.40

ng/l

1.57

704

Other bacterial diseases

345

1885

1.27

4.20

1.0

38.24

42.58

ng/l

1.32

234

1330

Dental caries 1 and operation codes

326

1304

1.28

4.20

1.0

44.17

42.46

ng/l

0.22

222

895

Fracture at wrist and hand level

110

730

1.51

4.16

1.0

38.13

41.61

ng/l

0.57

500

Cervicobrachial syndrome

502

1.62

4.15

1.0

26.67

43.12

ng/l

6.87

375

Hypothyreosis and Thyroxine purchase for inclusion criteria

319

1651

1.28

4.12

1.0

39.54

43.33

ng/l

0.61

205

1162

Polyneuropathies and other disorders of the peripheral nervous system

566

1.58

4.10

1.0

56.50

42.49

ng/l

0.27

373

Other chronic obstructive pulmonary disease, including avohilmo

116

1411

0.68

4.08

1.0

38.26

42.51

ng/l

0.60

941

Schizophrenia

324

1.77

4.03

1.0

32.71

45.37

ng/l

3.29

231

Retention of urine

133

779

1.45

4.00

1.0

43.45

42.36

ng/l

0.12

506

Gastro-oesophageal reflux disease

254

1733

1.30

3.96

1.0

40.24

42.59

ng/l

0.36

175

1199

Postmenopausal osteoporosis with pathological fracture

118

2.31

3.94

1.0

34.13

52.99

ng/l

1.85

Disorders of ocular muscles, binocular movement, accommodation and refraction

141

986

1.42

3.94

1.0

41.70

41.62

ng/l

0.01

689

Diseases of the eye and adnexa

274

1056

1.30

3.92

1.0

42.00

42.04

ng/l

0.00

198

781

Diplopia

298

1.79

3.90

1.0

31.73

45.12

ng/l

2.80

199

Hypothyroidism, other/unspecified

308

1600

1.27

3.89

1.0

38.93

43.51

ng/l

0.78

200

1127

Emotionally unstable personality disorder

138

2.18

3.88

1.0

30.19

42.45

ng/l

1.36

Visual disturbances

159

1150

1.39

3.85

1.0

36.08

44.19

ng/l

1.95

113

779

Injuries to the abdomen, lower back, lumbar spine and pelvis

126

869

1.44

3.84

1.0

58.23

42.49

ng/l

0.43

589

Cardiovascular diseases

159

617

1.41

3.82

1.0

40.53

42.25

ng/l

0.19

108

470

Cramp and spasm

2.55

3.80

1.1

1.0

46.09

46.13

ng/l

0.00

Other CVD

421

1.64

3.79

1.0

38.62

45.17

ng/l

0.72

268

All pneumoniae

346

1914

1.25

3.78

1.0

40.33

41.94

ng/l

0.10

241

1349

Other (not insulin) diabetes medications

360

1744

1.25

3.77

1.0

35.52

42.96

ng/l

2.68

247

1233

Biguanides

359

1780

1.24

3.74

1.0

35.24

43.07

ng/l

2.97

245

1264

Glucagon-like peptide-1 (GLP-1) analogues

223

1401

1.31

3.70

1.0

40.52

44.97

ng/l

0.59

146

961

Type 2 diabetes

358

1712

1.24

3.68

1.0

34.67

43.13

ng/l

3.64

250

1208

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1150

0.67

3.64

1.0

41.69

42.57

ng/l

0.06

806

Senile cataract

277

1346

1.28

3.63

1.0

42.13

44.46

ng/l

0.33

187

955

Pain in joint

197

978

1.34

3.60

1.0

46.61

42.30

ng/l

0.18

148

709

Injuries to the elbow and forearm

226

1573

1.30

3.58

1.0

42.64

42.45

ng/l

0.02

154

1094

Other and unspecified myopathies

191

1.95

3.57

1.0

39.69

44.48

ng/l

0.33

116

Hypoglycaemia, other or unspecified

117

2.23

3.57

1.1

1.0

43.19

44.93

ng/l

0.06

Hernia

333

1820

1.24

3.50

1.0

42.99

41.32

ng/l

0.10

218

1293

Any event in cancer register

231

1764

0.78

3.50

1.0

35.08

42.86

ng/l

2.87

166

1236

Injury, poisoning and certain other consequences of external causes

185

688

1.35

3.46

1.0

44.00

42.23

ng/l

0.24

125

485

Disorders of the thyroid gland

324

1704

1.24

3.44

1.0

38.91

43.53

ng/l

0.83

211

1204

Other/unspecified dorsalgia

119

833

1.42

3.43

1.0

32.05

43.72

ng/l

4.54

611

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

346

1713

1.23

3.40

1.0

35.78

43.14

ng/l

2.69

244

1208

Diabetes, insulin treatment (Kela reimbursement)

365

1822

1.23

3.37

1.0

35.47

42.74

ng/l

2.83

256

1279

Later onset COPD, excluding more controls

504

0.54

3.35

1.0

29.23

47.97

ng/l

4.91

320

Other and unspecified injuries of head

2.33

3.33

1.0

48.19

43.05

ng/l

0.18

Abdominal and pelvic pain

356

1454

1.23

3.32

1.0

40.76

41.83

ng/l

0.16

252

1018

Used for control exclusion in common control thyroid runs

364

1503

1.23

3.32

1.0

35.97

43.44

ng/l

2.55

245

1066

Other diseases of pleura

1148

0.68

3.31

1.0

40.36

43.45

ng/l

0.37

762

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

2.42

3.26

1.0

34.82

30.74

ng/l

0.12

Other specified/unspecified disorders of bone/cartilage

2.80

3.26

1.0

40.30

33.06

ng/l

—

Diverticular disease of intestine

283

1501

1.25

3.25

1.0

41.07

43.13

ng/l

0.31

193

1047

Malignant neoplasm

235

1772

0.79

3.24

1.0

35.82

42.75

ng/l

2.28

169

1243

Fibromyalgia

129

2.10

3.23

1.0

28.27

46.97

ng/l

2.70

Certain infectious and parasitic diseases

353

1440

1.23

3.22

1.0

37.88

43.49

ng/l

1.68

245

1005

Disorders of eyelid, lacrimal system and orbit

296

1871

1.24

3.22

1.0

39.11

42.57

ng/l

0.74

200

1297

Special screening examination for infectious and parasitic diseases

200

1.76

3.21

1.0

36.48

39.24

ng/l

0.28

165

Injury of muscle and tendon at shoulder and upper arm level

142

1043

1.36

3.21

1.0

46.03

42.03

ng/l

0.37

101

722

Fracture of forearm

183

1306

1.31

3.20

1.0

43.65

43.54

ng/l

0.01

125

913

Pedestrian injured in transport accident

130

2.09

3.18

1.0

41.29

44.15

ng/l

0.12

Meningitis

2.32

3.17

1.1

1.0

33.95

42.86

ng/l

—

Malignant neoplasm of colon

364

0.41

3.17

1.0

46.00

45.16

ng/l

—

232

Fracture of neck

124

2.11

3.14

1.1

1.0

42.36

39.72

ng/l

0.12

Pneumonias (Asthma/COPD co-morbidities)

339

1922

1.22

3.14

1.0

40.69

41.89

ng/l

0.07

236

1354

Migraine with aura and triptan purchases

172

1.92

3.13

1.0

28.25

42.85

ng/l

2.72

121

Disorders of vestibular function (Vertigo)

168

1263

1.32

3.12

1.0

42.38

44.15

ng/l

0.21

113

857

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

334

1920

1.22

3.11

1.0

41.06

41.82

ng/l

0.04

232

1352

Somatoform disorder

297

1.69

3.11

1.0

36.40

47.22

ng/l

1.42

199

Voice disturbances

623

1.46

3.08

1.0

62.35

44.12

ng/l

0.47

422

312

1588

1.23

3.07

1.0

41.21

43.00

ng/l

0.10

218

1117

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

312

1588

1.23

3.07

1.0

41.21

43.00

ng/l

0.10

218

1117

Persons encountering health services for other counselling and medical advice, not elsewhere classified

378

1785

1.21

3.02

1.0

35.04

43.96

ng/l

4.36

286

1214

Fracture of lumbar spine and pelvis

479

1.53

3.02

1.0

76.71

45.71

ng/l

0.48

306

Eating disorders

2.26

3.02

1.0

40.93

44.17

ng/l

0.11

Diarrhoea and gastroenteritis of presumed infectious origin

209

1485

1.28

3.01

1.0

38.38

41.80

ng/l

0.65

152

1006

Nontraumatic intracranial haemmorrhage

456

1.54

3.01

1.0

42.41

45.45

ng/l

0.21

293

Fissure and fistula of anal and rectal regions

610

1.46

3.00

1.0

36.92

43.53

ng/l

0.96

428

Volume depletion

175

1.89

2.99

1.0

29.25

47.06

ng/l

2.27

106

Fall on same level involving ice and snow

190

1473

1.29

2.98

1.0

43.27

43.09

ng/l

0.01

122

1020

COPD (mode)

808

0.66

2.97

1.0

38.36

44.06

ng/l

0.64

542

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

233

1732

0.79

2.97

1.0

36.33

42.56

ng/l

1.84

169

1214

Malignant neoplasm, wide definition for exclusion

233

1732

0.79

2.97

1.0

36.33

42.56

ng/l

1.84

169

1214

Vascular syndromes of brain in cerebrovascular disorders

2.55

2.96

1.1

1.0

37.56

40.43

ng/l

—

Unstable angina pectoris

988

0.69

2.92

1.0

32.21

43.71

ng/l

3.16

661

Other disorders of fluid, electrolyte and acid-base balance

106

728

1.41

2.90

1.0

30.10

46.43

ng/l

6.34

476

Disorders of choroid and retina

297

1764

1.23

2.90

1.0

39.83

43.38

ng/l

0.71

209

1216

Finngen Rheumatological endpoints

333

1561

1.22

2.89

1.0

39.99

42.70

ng/l

0.53

236

1101

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

234

1732

0.80

2.88

1.0

36.33

42.56

ng/l

1.84

169

1214

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

130

1208

0.74

2.88

1.1

1.0

37.84

45.54

ng/l

1.33

806

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

132

1220

0.74

2.87

1.1

1.0

37.53

45.48

ng/l

1.45

817

Exclusions for E4_PCOS_CONSORTIUM

211

1036

1.28

2.87

1.0

38.93

42.61

ng/l

0.60

160

725

Explicit Sepsis

109

750

1.40

2.86

1.0

38.58

46.27

ng/l

1.63

469

Type 2 diabetes, definitions combined

346

1709

1.21

2.84

1.0

35.06

43.17

ng/l

2.94

234

1206

Other fall from one level to another

471

1.51

2.82

1.0

39.83

42.59

ng/l

0.19

323

Amyloidosis, other/unspecified

3.10

2.82

1.1

1.0

45.36

49.63

ng/l

0.13

Mixed conductive and sensorineural hearing loss

299

1.65

2.79

1.0

42.49

44.07

ng/l

0.11

199

Malignant neoplasm of liver and intrahepatic bile ducts

0.00

2.79

0.0

1.0

—

43.18

—

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

0.00

2.78

0.0

1.0

—

46.50

—

Pain, not elsewhere classified

522

1.48

2.77

1.0

32.94

44.67

ng/l

3.09

370

Diseases of inner ear

193

1483

1.28

2.77

1.0

44.71

42.66

ng/l

0.26

131

1020

Peripheral arterial reconstruction

409

0.49

2.74

1.1

1.0

44.48

44.04

ng/l

0.03

256

3.00

2.70

1.0

29.40

44.71

ng/l

—

Gastrointestinal diseases

200

783

1.28

2.69

1.0

44.39

41.92

ng/l

0.32

130

543

Type 2 diabetes, strict (exclude DM1)

345

1715

1.20

2.68

1.0

35.06

43.13

ng/l

2.92

234

1211

Other disorders of eye and adnexa

264

1.67

2.68

1.0

35.27

45.72

ng/l

1.13

172

Atherosclerosis, excluding cerebral and coronary sclerosis

1002

0.71

2.68

1.0

42.39

44.02

ng/l

0.17

653

Disorders of synovium and tendon

174

1222

1.28

2.62

1.0

45.54

42.90

ng/l

0.30

134

860

In situ neoplasms

939

0.68

2.60

1.0

45.05

47.03

ng/l

0.15

609

Pain in thoracic spine

282

1.64

2.60

1.0

30.01

45.15

ng/l

2.39

208

Disorders of parathyroid gland

475

1.48

2.59

1.0

33.73

46.36

ng/l

2.36

312

Early lumbar disc prolapse, operated

100

2.10

2.58

1.0

34.44

37.53

ng/l

0.13

Other cataract

169

1017

1.29

2.57

1.0

42.50

45.07

ng/l

0.30

111

702

Endovascular or surgical operations to intracerebral aneurysms

156

1.87

2.57

1.1

1.0

51.43

48.28

ng/l

0.10

Disorders of other endocrine glands

126

930

1.33

2.55

1.0

33.27

42.65

ng/l

2.49

630

Other disorders of nervous system

128

1.96

2.55

1.0

37.42

44.49

ng/l

0.44

Hypothyroidism, drug reimbursement

146

1.77

2.54

1.0

43.91

43.31

ng/l

0.02

108

Bacterial infection, other or unspecified

181

1286

1.27

2.53

1.0

39.32

42.36

ng/l

0.61

126

872

Psoriasis

726

0.63

2.53

1.0

39.65

42.67

ng/l

0.17

508

Irritable bowel syndrome

591

1.42

2.53

1.0

43.07

43.68

ng/l

0.05

409

Pneumonia, organism unspecified

304

1827

1.20

2.52

1.0

42.52

42.21

ng/l

0.02

206

1289

Gingivitis and periodontal diseases

322

1382

1.20

2.51

1.0

41.24

41.37

ng/l

0.02

218

958

Exclusions for E4_PCOS_BROAD

324

1.58

2.50

1.0

33.36

44.51

ng/l

1.59

217

Abnormal findings in secretions and smears from cervix uteri vagina vulva

760

0.68

2.50

1.0

46.29

43.05

ng/l

0.19

553

Oedema, not elsewhere classified

681

1.39

2.50

1.0

37.68

45.02

ng/l

1.44

481

Type 2 diabetes, definitions combined, including avohilmo

341

1693

1.19

2.48

1.0

33.92

43.29

ng/l

4.11

233

1194

Bacterial meningitis

2.40

2.46

1.1

1.0

38.14

45.91

ng/l

—

Inguinal hernia

205

1104

1.25

2.46

1.0

35.91

41.59

ng/l

1.48

130

774

Impingement syndrome of shoulder

721

1.38

2.45

1.0

40.64

42.15

ng/l

0.16

500

Colonic or urogenital fistula

662

1.39

2.45

1.0

38.36

42.58

ng/l

0.52

459

Injuries to the wrist and hand

320

1943

1.19

2.44

1.0

38.17

42.11

ng/l

1.05

247

1344

Tramadol

288

1534

1.21

2.43

1.0

36.09

43.33

ng/l

3.00

207

1067

Propionic acid derivatives

314

1.43

2.43

1.0

41.54

44.40

ng/l

0.18

220

Carcinoma in situ of skin

204

0.39

2.41

1.1

1.0

56.38

47.26

ng/l

—

126

Hyperparathyroidism

419

1.49

2.40

1.0

34.94

47.03

ng/l

1.94

272

Pleural effusion

402

0.52

2.40

1.0

47.86

45.50

ng/l

0.13

252

Other disorders starting during childhood or adolescence

4.97

2.38

1.0

28.57

39.43

ng/l

—

Abnormal blood-pressure reading, without diagnosis

2.07

2.37

1.1

1.0

29.00

44.69

ng/l

—

Presbyopia

139

1.88

2.36

1.0

39.16

44.31

ng/l

0.20

Other disorders of penis

198

1.72

2.35

1.1

1.0

52.45

40.98

ng/l

0.85

126

Cardiomyopathy

527

0.59

2.35

1.0

34.00

42.47

ng/l

0.75

354

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

4.07

2.33

1.0

26.49

34.29

ng/l

—

Subjective visual disturbances

543

1.42

2.32

1.0

41.29

44.72

ng/l

0.39

376

Other gastritis (incl. Duodenitis)

585

1.40

2.32

1.0

42.03

43.44

ng/l

0.15

389

Weight loss

199

1.72

2.31

1.1

1.0

61.09

43.74

ng/l

0.45

124

Aortic aneurysm

625

0.63

2.31

1.0

41.71

42.28

ng/l

0.04

405

Osteoporosis

582

1.40

2.30

1.0

38.57

46.67

ng/l

1.25

387

Benign paroxysmal vertigo

713

1.36

2.30

1.1

1.0

38.93

44.16

ng/l

0.78

491

Valvular operations

434

0.55

2.28

1.0

53.22

43.53

ng/l

0.62

285

Superficial injury of abdomen, lower back and pelvis

285

1.58

2.27

1.0

31.87

43.73

ng/l

1.68

186

Assault by bodily force

2.07

2.27

1.1

1.0

34.79

33.48

ng/l

0.09

Substance use, excluding alcohol

357

1.52

2.26

1.1

1.0

33.41

42.53

ng/l

1.92

259

Intracerebral haemorrhage

262

1.61

2.25

1.0

47.50

46.75

ng/l

0.03

159

Insulin, intermediate and long-acting

182

1433

1.25

2.24

1.0

38.10

42.18

ng/l

0.77

124

977

Acute alcohol intoxication

598

1.39

2.23

1.0

38.94

41.61

ng/l

0.24

410

Benign neoplasm of brain and other parts of central nervous system

135

1.86

2.22

1.1

1.0

44.08

46.98

ng/l

0.13

Heart failure and antihypertensive medication

538

0.67

2.21

1.0

34.69

43.54

ng/l

1.64

403

Other disorders of lacrimal gland

112

847

1.32

2.21

1.0

41.15

45.79

ng/l

0.50

580

Other disorders of glucose regulation and pancreatic internal secretion

157

1.79

2.21

1.1

1.0

43.17

42.92

ng/l

0.01

Redundant prepuce, phimosis and paraphimosis

390

1.48

2.20

1.0

42.88

38.56

ng/l

0.17

260

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

719

0.73

2.19

1.0

36.44

41.00

ng/l

0.63

484

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

482

0.59

2.18

1.1

1.0

43.33

47.45

ng/l

0.27

317

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

647

0.65

2.16

1.0

46.55

48.33

ng/l

0.10

445

Strabismus

525

1.41

2.16

1.0

40.38

43.52

ng/l

0.24

364

Early lumbar disc prolapse operation

122

1.89

2.15

1.0

32.99

38.50

ng/l

0.30

Diseases of oral cavity, salivary glands and jaws

319

1382

1.18

2.15

1.0

40.70

41.37

ng/l

0.11

216

958

Abnormal weight loss

181

1.72

2.15

1.1

1.0

59.95

45.37

ng/l

0.34

110

Non-ischemic cardiomyopathy

729

0.70

2.14

1.0

41.31

45.07

ng/l

0.36

481

Hypo-osmolality and hyponatraemia

410

1.46

2.13

1.0

29.03

47.97

ng/l

8.34

269

Tonsillectomy and adenotomy

677

0.71

2.13

1.0

34.68

38.59

ng/l

0.59

496

Heart failure and bmi 25plus

629

0.70

2.12

1.0

33.10

41.21

ng/l

2.49

416

Osteoporosis with pathological fracture (FG)

152

1.78

2.12

1.0

34.13

51.84

ng/l

1.84

100

Coronary artery bypass grafting

666

0.70

2.11

1.0

40.95

42.81

ng/l

0.17

444

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

321

1854

1.18

2.11

1.0

40.37

41.98

ng/l

0.27

232

1299

Gout, strict definition

485

0.60

2.10

1.0

34.87

42.73

ng/l

0.70

316

Neuromuscular dysfunction of bladder

190

1.69

2.09

1.1

1.0

33.27

41.80

ng/l

0.69

124

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

700

0.74

2.09

1.0

36.00

41.18

ng/l

0.75

475

Rheumatism, unspecified

332

1.51

2.08

1.0

37.92

45.03

ng/l

0.65

222

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

161

1372

0.80

2.08

1.1

1.0

36.42

44.31

ng/l

1.77

108

937

Parodontitis or/and operation codes

207

1006

1.22

2.04

1.0

37.41

44.38

ng/l

1.42

142

717

Cough

137

1034

1.27

2.03

1.0

44.21

45.54

ng/l

0.12

107

701

Anorexia (incl.atypical)

2.41

2.02

1.1

1.0

26.00

37.65

ng/l

—

Abnormal findings on diagnostic imaging of lung

111

1398

0.77

2.01

1.0

39.32

43.40

ng/l

0.52

921

Atrial fibrillation and flutter with reimbursement

594

0.71

2.01

1.0

40.12

45.65

ng/l

0.66

442

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

845

0.76

1.99

1.0

40.92

46.47

ng/l

0.67

597

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

845

0.76

1.99

1.0

40.92

46.47

ng/l

0.67

597

Cardiomyopathy (excluding other)

388

0.57

1.96

1.0

35.06

43.11

ng/l

0.48

258

Unspecified urinary incontinence

194

1.66

1.96

1.0

47.23

43.87

ng/l

0.17

120

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

145

1244

0.80

1.94

1.1

1.0

37.86

45.18

ng/l

1.38

835

Other heart diseases

144

753

1.26

1.94

1.0

41.44

42.95

ng/l

0.19

566

Temporomandibular joint disorders

297

1.52

1.94

1.0

39.30

43.69

ng/l

0.37

224

Ocular pain

135

1.78

1.91

1.1

1.0

32.05

46.85

ng/l

1.36

Non-rheumatic valve diseases

129

1190

0.79

1.91

1.0

43.66

42.61

ng/l

0.11

818

Any reimbursement code in KELA

165

664

1.25

1.88

1.0

36.86

41.83

ng/l

0.80

107

491

Hypertensive heart and/or renal disease

617

0.70

1.88

1.0

41.39

45.95

ng/l

0.43

403

Acute alcohol intoxication, ICD10

448

1.41

1.88

1.0

36.52

42.46

ng/l

0.64

312

Diabetic retinopathy, excluding more controls

329

1.37

1.87

1.0

29.76

38.70

ng/l

1.86

231

Primary gonarthrosis, bilateral

132

1448

0.80

1.86

1.0

39.62

44.21

ng/l

0.79

997

Colectomy operation

431

0.60

1.85

1.0

46.12

44.02

ng/l

0.09

285

Renal tubulo-interstitial diseases

280

1831

1.17

1.85

1.0

41.16

42.96

ng/l

0.34

197

1259

Fibroblastic disorders

595

1.35

1.83

1.0

40.29

43.51

ng/l

0.38

406

Cardiomyopathies, Primary/intrinsic

379

0.58

1.82

1.0

35.06

42.55

ng/l

0.44

253

Hypertensive Heart Disease

569

0.69

1.82

1.0

40.23

46.59

ng/l

0.64

368

Gout, unspecified

562

0.66

1.81

1.0

41.57

42.80

ng/l

0.08

365

Psoriatic arthropathies

235

0.47

1.80

1.0

19.83

46.56

ng/l

—

165

Benign neoplasm: Colon, unspecified

759

0.71

1.80

1.0

40.96

44.60

ng/l

0.32

493

Other respiratory diseases principally affecting the interstitium

439

0.61

1.79

1.0

35.94

44.61

ng/l

0.44

285

Allergic rhinitis

515

1.37

1.79

1.0

40.26

41.89

ng/l

0.13

359

Abnormal findings on diagnostic imaging of other body structures

300

0.53

1.78

1.0

32.50

45.87

ng/l

—

195

Alcohol abuse, main dg

336

1.46

1.78

1.0

38.02

42.29

ng/l

0.38

234

Paracetamol of NSAID medication

157

1.51

1.78

1.0

35.18

47.70

ng/l

1.24

120

Melanocytic naevi

702

0.70

1.77

1.0

39.24

43.28

ng/l

0.28

473

Peripheral artery disease

103

1064

0.78

1.77

1.0

40.77

43.80

ng/l

0.40

698

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

147

1169

1.24

1.76

1.0

41.39

42.97

ng/l

0.16

105

829

Autoimmune diseases excluding thyroid diseases

335

1609

1.16

1.76

1.0

38.14

42.88

ng/l

1.35

248

1142

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

349

0.57

1.75

1.1

1.0

34.07

46.45

ng/l

0.94

220

Hypertrophic disorders of skin

2.03

1.75

1.0

20.75

43.45

ng/l

—

Fall on and from stairs and steps

574

1.34

1.75

1.0

41.18

43.87

ng/l

0.28

399

Disorders of sclera, cornea, iris and ciliary body

166

1363

1.22

1.74

1.0

40.14

41.16

ng/l

0.13

120

939

Fall involving bed

2.24

1.74

1.1

1.0

52.40

35.86

ng/l

—

Bronchitis, not specified as acute or chronic

193

1.61

1.74

1.1

1.0

57.00

42.89

ng/l

0.47

119

Other disorders of the musculoskeletal system and connective tissue

355

1.44

1.73

1.1

1.0

34.92

45.05

ng/l

1.25

241

Myocardial infarction, strict

125

1141

0.80

1.73

1.0

43.69

43.18

ng/l

0.05

784

Other postsurgical states

140

1.72

1.71

1.0

26.60

42.00

ng/l

—

Hepatocellular carcinoma

0.00

1.71

0.0

1.0

—

39.95

—

Early onset COPD

673

0.70

1.71

1.0

43.55

43.56

ng/l

0.00

457

Viral and other specified intestinal infections

228

1.54

1.70

1.1

1.0

44.68

41.48

ng/l

0.17

148

Other medical care

1028

0.76

1.70

1.0

38.25

44.50

ng/l

0.78

661

Pain associated with micturition

258

1.52

1.70

1.0

33.65

42.02

ng/l

1.04

167

Autoimmune diseases excluding thyroid diseases, strict definition

326

1574

1.15

1.70

1.0

38.43

43.01

ng/l

1.19

240

1114

Other specific joint derangements/joint disorders

219

1235

1.19

1.70

1.0

46.10

41.30

ng/l

0.23

159

874

Acute tubulo-interstitial nephritis

195

1445

1.20

1.69

1.0

40.09

44.26

ng/l

0.86

136

964

Gout, idiopatic and unspecified

683

0.70

1.69

1.0

41.67

42.30

ng/l

0.05

453

Renal failure

1075

0.77

1.69

1.0

42.04

44.10

ng/l

0.20

706

Malignant neoplasm of small intestine

0.00

1.69

0.0

1.0

—

43.43

—

Vasomotor and allergic rhinitis

100

767

1.29

1.68

1.0

38.92

42.64

ng/l

0.38

543

Nausea and vomiting

543

1.34

1.67

1.0

48.23

42.97

ng/l

0.27

360

Use of pramipexole

536

1.35

1.66

1.0

40.25

45.84

ng/l

0.69

361

Valvular heart disease excluding rheumatic fever

132

1193

0.81

1.66

1.0

43.99

42.59

ng/l

0.16

821

Aneurysms, operations, SAH

392

1.41

1.65

1.0

46.52

45.65

ng/l

0.04

260

Allergic conjunctivitis

151

1216

1.22

1.65

1.0

41.97

42.77

ng/l

0.08

108

864

Maternal care related to the fetus and amniotic cavity and possible delivery problems

513

0.73

1.65

1.0

34.57

41.03

ng/l

0.77

392

Use of disulfiram, acamprosate or naltrexone

196

1.59

1.65

1.0

31.56

40.91

ng/l

1.27

135

Hemiplegia

1.90

1.65

1.1

1.0

27.83

47.05

ng/l

2.02

Ménière disease

228

1.54

1.64

1.0

44.90

45.44

ng/l

0.02

140

Persons encountering health services in other circumstances

105

825

1.27

1.64

1.0

38.70

43.93

ng/l

0.98

554

Hyperlipidaemia, other/unspecified

139

1068

1.23

1.64

1.0

41.51

44.10

ng/l

0.29

105

698

Disorders of conjunctiva

238

1699

1.17

1.64

1.0

42.22

42.44

ng/l

0.02

170

1187

Postpartum haemorrhage

265

0.56

1.63

1.0

59.81

38.84

ng/l

0.41

206

Polycystic ovarian syndrome, consortium definition

187

938

1.20

1.63

1.0

37.74

45.20

ng/l

1.54

128

674

In situ neoplasms

896

0.75

1.62

1.0

45.05

44.43

ng/l

0.05

592

Conjunctivitis

209

1539

1.18

1.61

1.0

41.29

42.49

ng/l

0.11

147

1082

Anterior Iridocyclitis

462

1.37

1.61

1.0

38.83

44.50

ng/l

0.78

325

Superficial injury of lower leg

488

1.35

1.60

1.0

38.51

44.52

ng/l

0.71

336

661

0.72

1.60

1.1

1.0

42.66

45.30

ng/l

0.19

414

Other intracranial haemorrhages

2.08

1.60

1.1

1.0

26.80

44.42

ng/l

—

Other noninfective gastroenteritis and colitis

488

1.35

1.59

1.0

31.13

45.52

ng/l

3.97

333

Psoriasis vulgaris

461

0.65

1.58

1.0

34.78

43.42

ng/l

0.59

330

Injuries to the neck

430

1.37

1.57

1.0

36.26

42.98

ng/l

0.75

304

Dental caries 2 and operation codes, only avohilmo

156

1172

0.83

1.57

1.0

39.19

43.57

ng/l

0.59

105

845

Carcinoma in situ of skin

175

0.46

1.57

1.1

1.0

56.38

47.37

ng/l

—

105

Abdominal aortic aneurysm (AAA)

233

0.51

1.56

1.0

25.83

43.79

ng/l

—

140

Cardiac arrhythmias

183

1010

1.20

1.56

1.0

41.12

43.50

ng/l

0.30

126

741

Radiculopathy

380

1.40

1.56

1.1

1.0

35.13

46.32

ng/l

2.08

269

Benign neoplasm of colon, rectum, anus and anal canal

224

1726

1.17

1.55

1.0

42.02

43.37

ng/l

0.15

161

1173

Complications of other internal prosthetic devices, implants and grafts

1.89

1.55

1.0

53.43

46.74

ng/l

—

Panic disorder

160

1.63

1.55

1.0

25.72

45.12

ng/l

3.94

107

Calcific aortic valvular stenosis

736

0.73

1.55

1.0

46.23

44.35

ng/l

0.12

458

Calcific aortic valvular stenosis, operated

736

0.73

1.55

1.0

46.23

44.35

ng/l

0.12

458

Asthma and allergy, excluding more controls

189

1.57

1.55

1.1

1.0

35.83

47.97

ng/l

1.04

129

Tooth eruption problems

1.89

1.55

1.0

29.10

43.25

ng/l

—

Autoimmune diseases

359

1611

1.14

1.54

1.0

37.29

42.88

ng/l

1.63

242

1142

Type 1 diabetes

508

1.34

1.54

1.0

40.91

43.25

ng/l

0.20

351

Actinic keratosis

994

0.77

1.54

1.0

41.82

45.67

ng/l

0.37

638

Operations 2 for CAVS

735

0.73

1.54

1.0

46.23

44.38

ng/l

0.12

457

Calcific aortic valvular stenosis, diagnosis (helper)

735

0.73

1.54

1.0

46.23

44.38

ng/l

0.12

457

Cardiomyopathy, other and unspecified

233

0.51

1.53

1.0

30.86

44.59

ng/l

—

148

Insulin medication

190

1369

1.19

1.53

1.0

38.13

42.58

ng/l

0.90

129

940

Malignant neoplasm of heart, mediastinum and pleura, excluding all cancers (controls excluding all cancers)

0.00

1.53

0.0

1.0

—

48.67

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

795

0.76

1.53

1.0

38.45

47.32

ng/l

1.18

558

Arthrosis

261

1235

1.16

1.52

1.0

37.88

41.46

ng/l

0.79

186

871

Pneumocystosis

0.00

1.52

0.0

1.0

—

36.93

—

Crowding of teeth, including avohilmo

0.00

1.51

0.0

1.0

—

35.27

—

Other arthrosis

199

1204

1.18

1.51

1.0

37.45

41.91

ng/l

0.94

147

854

Myocardial infarction, with ST-elevation

443

0.65

1.50

1.0

52.28

42.74

ng/l

0.41

287

Excessive vomiting in pregnancy

108

1.76

1.50

1.0

36.69

50.17

ng/l

0.92

Benign neoplasm of other and unspecified endocrine glands

308

1.43

1.49

1.0

32.98

45.02

ng/l

1.71

203

Polyuria

573

1.31

1.49

1.0

48.59

42.99

ng/l

0.65

376

Malignant melanoma, excluding all cancers (controls excluding all cancers)

501

0.68

1.48

1.0

33.30

45.59

ng/l

1.45

323

Acute and subacute iridocyclitis

435

1.36

1.48

1.1

1.0

37.71

44.60

ng/l

1.07

309

Diseases of tongue

139

1.66

1.48

1.0

30.62

48.46

ng/l

1.90

Lesion of sciatic nerve

1.82

1.47

1.0

30.69

44.89

ng/l

—

Psoriatic and enteropathic arthropathies

268

0.56

1.47

1.0

24.33

45.03

ng/l

—

191

Asthma and allergy

192

1.55

1.46

1.1

1.0

35.83

47.81

ng/l

1.02

131

Drug-induced neutropenia

169

0.47

1.46

1.0

58.00

45.17

ng/l

—

108

Malignant neoplasm of prostate

104

820

0.80

1.45

1.0

38.73

41.31

ng/l

0.29

545

Other disorders of bladder

277

1.45

1.44

1.0

30.61

44.40

ng/l

2.13

176

Allergic asthma (mode)

446

1.34

1.44

1.0

40.73

45.13

ng/l

0.32

309

L02BG Aromatase inhibitors

810

0.75

1.44

1.0

38.72

47.08

ng/l

0.96

557

Antihypertensive medication - note that there are other indications

150

677

1.21

1.44

1.0

42.55

42.17

ng/l

0.03

520

Benign neoplasm of brain and other parts of central nervous system

156

1.61

1.43

1.1

1.0

44.08

49.69

ng/l

0.27

Hypertrophic scar

1.98

1.43

1.0

13.71

41.72

ng/l

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

762

1.26

1.43

1.0

33.75

44.02

ng/l

2.53

529

Cerebral aneurysm, nonruptured

204

1.52

1.43

1.0

56.56

44.78

ng/l

0.63

133

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

847

0.77

1.42

1.1

1.0

40.73

44.14

ng/l

0.34

618

Calcific aortic valvular stenosis, including rheumatic fever

735

0.74

1.42

1.0

46.11

44.38

ng/l

0.11

457

Heart failure, not strict

222

1776

0.86

1.41

1.0

40.24

43.30

ng/l

0.53

152

1243

Asthma (mode)

265

1263

1.15

1.41

1.0

46.90

42.45

ng/l

0.24

182

880

Postpartum hemorraghe, parous women as controls

254

0.59

1.41

1.0

59.81

40.02

ng/l

0.38

196

Diaphragmatic hernia

121

988

1.23

1.41

1.0

35.93

43.87

ng/l

1.38

681

Allergic asthma (mode), excluding more controls

448

1.34

1.40

1.0

40.73

44.75

ng/l

0.29

308

Other enthesopathies

773

1.26

1.40

1.0

39.54

44.65

ng/l

0.53

542

Pneumonitis due to solids and liquids

157

1.60

1.40

1.0

44.48

43.91

ng/l

0.02

Osteopathies and chondropathies

173

1386

1.18

1.40

1.0

38.43

43.94

ng/l

1.06

115

956

Myocardial infarction

140

1210

0.83

1.39

1.0

43.11

42.91

ng/l

0.02

836

Ascites

178

0.50

1.39

1.0

69.22

43.02

ng/l

—

114

Chronic periodontitis, complicated

250

0.56

1.38

1.1

1.0

53.93

44.88

ng/l

0.29

169

Benign neoplasm of meninges

230

1.48

1.38

1.0

33.23

45.36

ng/l

1.21

143

Glaucoma

193

1446

1.17

1.38

1.0

42.87

44.12

ng/l

0.15

121

976

Malignant immunoproliferative diseases

2.64

1.37

1.2

1.0

34.67

38.09

ng/l

—

Other strabismus

406

1.35

1.37

1.0

41.15

43.74

ng/l

0.16

285

Malignant neoplasm of skin

163

1453

0.84

1.36

1.0

37.35

45.20

ng/l

1.73

100

977

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

420

0.67

1.36

1.0

30.95

45.26

ng/l

1.50

268

Benign neoplasm: Cerebral meninges

215

1.49

1.35

1.0

33.86

46.22

ng/l

1.16

135

ILD medications: immunosuppressive drugs

148

1690

0.84

1.35

1.0

41.09

41.04

ng/l

0.01

109

1198

Fentanyl

235

0.55

1.35

1.0

47.13

49.43

ng/l

—

145

Drug-induced osteoporosis with pathological fracture

0.00

1.35

0.0

1.0

—

41.81

—

Laparoscopic left hemicolectomy

0.00

1.34

0.0

1.0

—

30.91

—

Assault

191

1.52

1.34

1.0

36.35

39.88

ng/l

0.32

130

Diseases of liver

901

0.78

1.33

1.0

39.65

42.18

ng/l

0.19

618

Keratitis

797

1.24

1.33

1.0

40.06

41.62

ng/l

0.14

544

Benign neoplasm: Sigmoid colon

505

1.31

1.33

1.0

34.21

43.59

ng/l

1.16

340

Endometriosis

449

1.26

1.33

1.0

44.30

44.35

ng/l

0.00

313

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

453

0.68

1.33

1.0

30.92

45.50

ng/l

3.36

287

malignant neoplasm of male genital organs

106

828

0.81

1.31

1.0

38.78

41.31

ng/l

0.29

551

Basal cell carcinoma, including avohilmo

147

1377

0.84

1.31

1.1

1.0

37.28

45.64

ng/l

1.74

918

Bacterial, viral and other infectious agents

152

1.58

1.31

1.0

40.94

37.95

ng/l

0.15

Oligomenorrhoea

0.00

1.31

0.0

1.0

—

56.85

—

Retinal detachments and breaks

119

979

1.22

1.31

1.0

44.62

42.83

ng/l

0.17

656

Malignant immunoproliferative diseases

2.53

1.31

1.2

1.0

34.67

39.21

ng/l

—

Other interstitial pulmonary diseases

380

0.66

1.30

1.0

35.43

44.95

ng/l

0.41

243

Medicines for HER+ breast cancer

940

0.79

1.30

1.1

1.0

38.72

46.04

ng/l

0.96

653

Disorders of skin appendages

125

1034

1.21

1.29

1.0

38.37

40.94

ng/l

0.35

724

Interstitial lung disease endpoints

379

0.66

1.29

1.0

35.43

45.02

ng/l

0.42

242

Interstitial lung disease

379

0.66

1.29

1.0

35.43

45.02

ng/l

0.42

242

Ganglion

464

1.32

1.28

1.0

48.97

42.79

ng/l

0.44

325

Inflammatory diseases of prostate (prostatitis)

318

1.39

1.28

1.1

1.0

41.12

41.98

ng/l

0.06

212

Vocal cord dysfunction

256

1.42

1.28

1.0

48.71

45.72

ng/l

0.14

184

Papulosquamous disorders

1072

0.80

1.27

1.0

41.78

42.39

ng/l

0.05

745

Benign mammary dysplasia

319

1.38

1.26

1.0

45.06

45.29

ng/l

0.01

223

ILD, hospital admissions

377

0.66

1.26

1.0

35.43

45.02

ng/l

0.42

242

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

328

0.64

1.26

1.0

46.54

44.68

ng/l

0.09

196

Chronic diseases of tonsils and adenoids

191

1405

0.86

1.26

1.0

41.21

41.31

ng/l

0.01

143

1002

Primary open-angle glaucoma, strict

685

1.25

1.26

1.0

44.97

45.11

ng/l

0.01

444

Anti-inflammatory and antirheumatic products, non-steroids

314

1.28

1.26

1.0

37.69

44.40

ng/l

0.74

220

Viral conjunctivitis

2.41

1.24

1.0

31.50

33.17

ng/l

—

Female genital prolapse

445

1.25

1.24

1.0

57.24

44.44

ng/l

0.26

311

Disorders of lacrimal system

130

1086

1.20

1.24

1.0

40.21

45.16

ng/l

0.64

734

Benign neoplasm: Colon

183

1541

1.16

1.24

1.0

41.31

42.80

ng/l

0.14

126

1036

Small fibre neuropathy

1.92

1.23

1.1

1.0

19.71

46.99

ng/l

—

Appendectomy

138

1576

0.84

1.23

1.0

40.48

41.37

ng/l

0.10

101

1103

Basal cell carcinoma

144

1357

0.84

1.23

1.1

1.0

37.57

44.20

ng/l

1.35

904

Car occupant injured in other and unspecified transport accidents

338

1.36

1.22

1.1

1.0

38.76

45.18

ng/l

0.47

229

Congenital malformations of genital organs

1.73

1.22

1.0

51.82

50.16

ng/l

0.04

Reimbursement for rheumatic diseases

133

1577

0.84

1.22

1.0

41.98

42.42

ng/l

0.04

1100

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

2.66

1.22

1.2

1.0

39.40

35.56

ng/l

—

Haemorrhage, not elsewhere classified

1.97

1.22

1.1

1.0

67.20

40.55

ng/l

—

Other and unspecified injuries of wrist and hand

2.05

1.22

1.1

1.0

23.66

44.46

ng/l

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

252

0.59

1.21

1.0

43.39

44.04

ng/l

—

177

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

116

1.65

1.21

1.0

38.19

46.43

ng/l

0.62

Gonarthrosis

244

1225

1.14

1.21

1.0

38.61

41.61

ng/l

0.61

162

864

Abnormal spermatozoa

349

0.66

1.21

1.0

47.56

41.61

ng/l

0.17

227

Palmar fascial fibromatosis [Dupuytren]

408

1.33

1.21

1.0

40.89

43.82

ng/l

0.25

274

Pulmonary heart disease, diseases of pulmonary circulation

809

0.78

1.21

1.0

33.60

43.61

ng/l

2.33

541

Degenerative macular diseases

288

1.39

1.21

1.0

40.71

43.80

ng/l

0.20

177

Superficial injury of thorax

322

1.37

1.21

1.0

36.00

43.42

ng/l

0.81

219

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

288

0.62

1.20

1.0

33.33

46.53

ng/l

1.87

176

Spondylolisthesis/Spondylolysis

417

1.32

1.20

1.0

32.44

44.92

ng/l

2.55

302

Other noninflammatory disorders of vagina

132

1.59

1.20

1.0

36.75

53.53

ng/l

1.08

Myocardial infarction, without ST-elevation

1043

0.81

1.20

1.0

46.35

43.03

ng/l

0.34

689

Functional dyspepsia

629

1.26

1.19

1.0

35.63

43.48

ng/l

1.31

424

Other specified and unspecified retinal disorders

1.84

1.19

1.0

60.14

39.96

ng/l

—

Leisure time condition

357

1.35

1.19

1.0

44.22

45.22

ng/l

0.05

237

Myalgia

470

1.30

1.19

1.0

41.44

42.30

ng/l

0.05

329

Other malignant neoplasms of skin (=non-melanoma skin cancer)

142

1323

0.85

1.19

1.1

1.0

37.84

44.21

ng/l

1.28

882

Chronic gastritis

764

1.23

1.19

1.0

37.29

43.02

ng/l

0.95

496

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

2.31

1.18

1.2

1.0

29.83

34.69

ng/l

—

Fracture of shoulder and upper arm

104

854

1.22

1.18

1.0

36.14

43.15

ng/l

1.09

583

Dialysis, with operation codes

335

0.66

1.18

1.0

43.98

43.64

ng/l

0.01

233

Malignant neoplasm of breast, HER-positive

916

0.80

1.18

1.0

38.87

46.25

ng/l

0.94

639

Myocardial infarction, unclassifiable

477

0.73

1.18

1.0

46.57

44.49

ng/l

0.13

295

Coxibs

313

1.28

1.17

1.0

39.26

44.55

ng/l

0.64

219

Acute renal failure

522

0.73

1.17

1.0

41.18

44.31

ng/l

0.19

337

Use of antiglaucoma preparations and miotics

165

1.52

1.17

1.0

37.12

44.16

ng/l

0.45

102

Insulin, combination of fast acting with intermediate-acting or long-acting

190

1518

1.15

1.16

1.0

38.13

41.97

ng/l

0.74

129

1031

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

393

0.69

1.16

1.0

38.89

44.98

ng/l

0.82

245

Acetic acid derivatives and related substances

312

1.27

1.14

1.0

43.59

44.69

ng/l

0.08

218

Paralytic strabismus

158

1.52

1.14

1.0

33.43

46.26

ng/l

1.00

1067

0.82

1.14

1.0

40.59

45.11

ng/l

0.49

685

Inflammatory diseases of female pelvic organs

154

990

1.17

1.14

1.0

49.09

43.09

ng/l

0.20

112

700

Complications of surgical and medical care, not elsewhere classified

311

1996

1.12

1.13

1.0

40.19

42.03

ng/l

0.36

215

1398

Dental caries 2

164

1496

0.86

1.13

1.0

38.26

41.54

ng/l

0.46

112

1067

DVT of lower extremities

495

0.73

1.13

1.0

45.62

43.54

ng/l

0.14

337

Dysplasia of cervi uteri

321

0.70

1.12

1.0

40.00

44.36

ng/l

0.21

230

Other/unspecified enthesopathies, not elsewhere classified

200

1.45

1.12

1.0

38.50

47.28

ng/l

0.70

135

Cerebral palsy and other paralytic syndromes

225

1.42

1.11

1.0

31.68

44.01

ng/l

1.96

139

Other diseases of liver

436

0.71

1.11

1.0

39.75

44.27

ng/l

0.18

303

Noninfective enteritis and colitis

127

1070

1.19

1.11

1.0

32.78

41.79

ng/l

2.63

732

Melanocytic naevi

642

0.76

1.11

1.0

39.24

43.17

ng/l

0.27

444

Deviated nasal septum

112

934

1.20

1.11

1.1

1.0

33.38

39.78

ng/l

1.79

648

Diseases of arteries, arterioles and capillaries

178

1530

0.87

1.10

1.0

39.07

42.96

ng/l

0.81

125

1021

Supplementary factors related to causes of morbidity and mortality classified elsewhere

655

1.24

1.09

1.0

43.86

42.58

ng/l

0.10

449

Neuralgia and neuritis, unspecified

104

1.64

1.09

1.0

32.01

43.93

ng/l

—

Trochanteric bursitis

294

1.36

1.09

1.0

47.39

45.30

ng/l

0.08

199

Type of accident

611

1.25

1.08

1.0

45.44

42.64

ng/l

0.22

418

Major coronary heart disease event excluding revascularizations

193

1524

0.87

1.08

1.0

40.18

42.35

ng/l

0.34

124

1048

Tongue abnormality

136

1.55

1.08

1.0

32.64

49.26

ng/l

1.37

Other maltreatment syndromes

2.19

1.08

1.0

29.57

30.96

ng/l

—

Disorders of breast

129

1013

1.18

1.07

1.0

53.69

42.77

ng/l

0.34

715

Systemic atrophies primarily affecting the central nervous system

1.69

1.07

1.0

33.50

44.32

ng/l

—

Benign neoplasm: Colon, unspecified

694

0.78

1.07

1.0

40.96

44.23

ng/l

0.28

460

Ulcer of oesophagus

169

1.48

1.07

1.0

28.38

40.06

ng/l

1.26

101

Iridocyclitis

514

1.27

1.07

1.0

38.68

42.95

ng/l

0.56

358

Follow-up examination after treatment for malignant neoplasms

169

1.48

1.07

1.1

1.0

40.56

51.65

ng/l

0.98

122

Primary_lymphoid and hematopoietic malignant neoplasms

693

0.78

1.06

1.1

1.0

38.72

44.86

ng/l

0.71

461

Ulcerative proctitis

1.65

1.06

1.0

34.36

47.57

ng/l

0.85

Other retinal disorders

204

1438

1.14

1.06

1.0

39.95

43.73

ng/l

0.61

135

962

DVT of lower extremities and pulmonary embolism

1109

0.83

1.06

1.0

36.69

43.16

ng/l

1.37

744

Dental caries 3 and operation codes, only avohilmo

390

1.22

1.06

1.0

43.29

49.52

ng/l

0.40

275

Deforming dorsopathies

622

1.24

1.06

1.0

33.74

43.53

ng/l

2.31

458

Glaucoma suspect

116

977

1.19

1.05

1.0

40.75

42.91

ng/l

0.23

656

Viral pneumonia

262

1.38

1.05

1.0

28.31

44.45

ng/l

3.50

177

Disorders of refraction and accommodation

478

1.27

1.05

1.0

44.27

43.19

ng/l

0.07

340

Nonspecific lymphadenitis

123

0.49

1.05

1.0

35.00

45.72

ng/l

—

Dental caries 2, only avohilmo

160

1457

0.87

1.05

1.0

38.63

41.49

ng/l

0.37

108

1037

Enthesopathies of lower limb, excluding foot

498

1.27

1.04

1.0

33.01

43.54

ng/l

1.41

374

Asthma, excluding more controls

257

1217

1.13

1.04

1.0

46.64

42.52

ng/l

0.21

178

850

Other diseases of the respiratory system

487

0.74

1.04

1.1

1.0

33.08

44.30

ng/l

1.18

314

Other respiratory disorders and diseases

487

0.74

1.04

1.1

1.0

33.08

44.30

ng/l

1.18

314

Brachial plexus disorders

154

1.50

1.03

1.0

31.15

41.72

ng/l

1.68

106

Hypothermia

2.07

1.03

1.0

32.57

35.64

ng/l

—

Viral hepatitis

114

1.58

1.02

1.1

1.0

32.64

38.92

ng/l

0.51

Subarachnoid haemorrhage

255

1.38

1.02

1.0

46.00

45.30

ng/l

0.02

164

Abnormal findings on examination of blood, without diagnosis

149

1202

1.16

1.02

1.0

37.00

42.77

ng/l

1.15

103

810

Oxicams

312

1.26

1.01

1.0

40.92

44.69

ng/l

0.30

218

Chronic kidney disease

718

0.79

1.01

1.0

41.60

43.50

ng/l

0.14

463

Sequelae of injuries of upper limb

213

1.41

1.01

1.1

1.0

41.45

44.84

ng/l

0.22

139

Thyrotoxicosis with diffuse goitre

275

0.65

1.01

1.0

38.42

45.65

ng/l

0.27

191

Benign neoplasms

305

1532

1.11

1.01

1.0

41.70

40.46

ng/l

0.19

222

1059

Dental caries 2 and operation codes

161

1471

0.87

1.01

1.0

38.57

41.64

ng/l

0.41

110

1050

Retinal detachment with retinal break

342

1.32

1.01

1.1

1.0

50.86

43.62

ng/l

0.39

228

malignant neoplasm of female genital organs

334

0.69

1.01

1.1

1.0

34.71

47.50

ng/l

1.78

228

Acute pharyngitis

220

1.40

1.01

1.0

31.38

43.08

ng/l

1.53

152

Ischemic heart diseases

300

1691

1.11

1.00

1.0

40.50

42.55

ng/l

0.30

196

1205

Coxarthrosis, primary, with hip surgery

119

1325

0.85

1.00

1.0

39.37

43.92

ng/l

0.65

882

Dermatophytosis

333

0.69

0.99

1.0

33.35

44.38

ng/l

1.18

224

Diabetic neuropathy

221

1.40

0.99

1.1

1.0

35.19

36.23

ng/l

0.06

152

Gonarthrosis, primary, with knee surgery

165

1544

0.87

0.99

1.0

45.74

43.67

ng/l

0.24

1067

Other and unspecified nerve root and plexus disorders, also in other diseases

440

1.27

0.99

1.0

42.88

41.64

ng/l

0.07

302

Coronary revascularization (ANGIO or CABG)

133

1081

0.86

0.99

1.0

39.03

43.15

ng/l

0.63

742

First line medication for Crohn's disease

298

1802

0.90

0.98

1.0

39.12

40.85

ng/l

0.34

209

1266

Ulcer of lower limb, not elsewhere classified

332

0.69

0.98

1.0

42.88

43.95

ng/l

0.06

215

Drug-induced osteoporosis

0.00

0.98

0.0

1.0

—

39.02

—

Carcinoma in situ of skin of ear and external auricular canal

0.00

0.98

0.0

1.0

—

45.18

—

Portal vein thrombosis

0.00

0.98

0.0

1.0

—

32.48

—

Inflammation of lacrimal passages (acute and unspecified)

0.00

0.98

0.0

1.0

—

48.22

—

Vitamin deficiency

1.67

0.98

1.0

22.11

49.01

ng/l

—

Vitamin deficiency, wide

1.67

0.98

1.0

22.11

49.01

ng/l

—

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

0.00

0.97

0.0

1.0

—

43.81

—

Universal erythroderma, KELA reimbursement

0.00

0.97

0.0

1.0

—

33.71

—

Skin changes due to chronic exposure to nonionizing radiation

1011

0.83

0.97

1.0

41.59

45.36

ng/l

0.38

653

Insulin, fast-acting (human)

249

1.37

0.97

1.0

36.68

44.71

ng/l

0.84

164

Acute nasopharyngitis (common cold)

239

1.37

0.97

1.0

32.00

40.46

ng/l

0.59

174

Episcleritis

1.64

0.97

1.1

1.0

42.84

43.72

ng/l

—

Heterophoria

124

1.54

0.96

1.0

34.30

45.59

ng/l

—

Malignant melanoma

377

0.71

0.96

1.0

36.61

45.52

ng/l

0.74

248

Early onset COPD, excluding more controls

604

0.78

0.96

1.0

43.55

44.53

ng/l

0.05

412

Type 1 diabetes, wide definition, subgroup 1

397

1.28

0.96

1.0

41.51

42.64

ng/l

0.08

280

Other follicular disorders

116

1.56

0.96

1.0

46.08

42.77

ng/l

0.14

Artrosis, including avohilmo

288

1422

1.11

0.96

1.0

38.75

42.65

ng/l

0.78

200

1014

Mouth breathing

129

1106

1.17

0.96

1.0

32.89

41.12

ng/l

2.27

769

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

549

1.24

0.96

1.0

39.67

42.00

ng/l

0.16

387

Dental caries 1 and operation codes, only avohilmo

350

1.22

0.95

1.0

44.52

51.13

ng/l

0.38

245

Secondary malignant neoplasm of other and unspecified sites

0.00

0.95

0.0

1.0

—

44.05

—

Neuroendocrine tumor and carcinoma of small intestine

0.00

0.95

0.0

1.0

—

32.83

—

Nephropathy related operations

306

0.68

0.95

1.0

40.54

43.23

ng/l

0.11

211

Collagenous colitis

191

1.42

0.94

1.0

35.10

47.13

ng/l

1.08

122

Meniscus derangement

202

1223

1.13

0.94

1.0

45.39

41.62

ng/l

0.70

152

866

Malignant neoplasm of breast

118

996

0.85

0.94

1.0

41.54

44.78

ng/l

0.37

701

Disorder of lipoprotein metabolism, unspecified

364

1.29

0.94

1.0

46.00

46.95

ng/l

0.05

235

Asthma mixed form (mode)

118

0.51

0.94

1.0

71.83

48.47

ng/l

—

Visual impairment including blindness (binocular or monocular)

109

1.56

0.93

1.0

53.83

46.90

ng/l

0.19

Asthma mixed form (mode), excluding more controls

120

0.50

0.93

1.0

71.83

49.15

ng/l

—

Fitting and adjustment of other devices

113

895

1.18

0.93

1.0

50.04

44.78

ng/l

0.62

572

Postpartum hemorraghe, all women as controls

256

0.66

0.93

1.0

59.81

41.01

ng/l

0.36

197

Panniculitis affecting regions of neck and back

1.72

0.92

1.1

1.0

32.67

49.92

ng/l

—

ILD, hospital admissions 1, main diag only

339

0.71

0.92

1.0

35.43

46.46

ng/l

0.50

215

Budesonide

295

1.32

0.92

1.0

36.44

44.64

ng/l

0.65

209

Pain and other conditions associated with female genital organs and menstrual cycle

283

1.32

0.91

1.1

1.0

37.59

45.79

ng/l

0.80

203

Pedal cyclist injured in transport accident

455

1.25

0.90

1.0

34.31

43.74

ng/l

1.29

318

Emergency coronary revascularization (for ACS)

150

1234

0.87

0.90

1.0

39.53

43.21

ng/l

0.57

831

1.66

0.90

1.0

41.43

51.75

ng/l

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

170

1785

0.88

0.90

1.0

36.35

43.32

ng/l

1.66

132

1207

Appendicitis, broad definition

180

1858

0.89

0.90

1.1

1.0

38.39

41.33

ng/l

0.57

135

1317

Diseases of pulp and periapical tissues, including avohilmo

340

1610

1.10

0.89

1.0

42.71

41.52

ng/l

0.18

238

1109

Pulmonary embolism

741

0.81

0.89

1.1

1.0

32.22

44.11

ng/l

3.21

501

Gout, FINNGEN

818

0.82

0.89

1.0

38.11

42.39

ng/l

0.51

533

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

164

1412

1.14

0.89

1.1

1.0

39.23

41.78

ng/l

0.35

133

996

Other and unspecified tonsillitis

447

1.23

0.89

1.1

1.0

32.51

41.08

ng/l

1.28

322

Dental pulpitis 1

340

1611

1.10

0.88

1.0

42.52

41.53

ng/l

0.14

238

1110

Pulmonary heart disease

740

0.81

0.88

1.0

32.22

44.07

ng/l

3.19

500

Dental pulpitis 4

340

1611

1.10

0.88

1.0

42.52

41.53

ng/l

0.14

238

1110

L04AX Other immunosuppressants

128

1475

0.87

0.88

1.0

41.33

42.40

ng/l

0.10

1030

Dental pulpitis 4, only avohilmo

346

1651

1.09

0.87

1.0

41.98

41.39

ng/l

0.08

239

1142

Ischaemic heart disease, wide definition

297

1689

1.10

0.87

1.0

40.73

42.60

ng/l

0.27

195

1200

Second line medication for Crohn's disease

131

1505

0.87

0.86

1.0

40.91

42.40

ng/l

0.15

1048

Haemorrhage from respiratory passages

110

874

1.17

0.86

1.0

44.08

44.28

ng/l

0.01

575

Adjustment and management of implanted device

448

0.76

0.86

1.0

40.87

45.22

ng/l

0.42

275

Speech therapy

667

1.20

0.86

1.0

30.74

44.82

ng/l

5.54

448

Conduction disorders

759

0.83

0.86

1.0

39.05

44.45

ng/l

0.77

503

Acute appendicitis, with complications

504

0.77

0.85

1.1

1.0

45.33

42.75

ng/l

0.15

349

Malignant neoplasm of breast, HER2-negative

116

989

0.86

0.85

1.0

42.19

44.91

ng/l

0.29

696

Polypectomy (DHB20)

170

1.42

0.85

1.0

27.27

44.68

ng/l

2.81

107

Other diseases of blood and blood-forming organs, wide

548

0.78

0.85

1.0

47.16

44.67

ng/l

0.17

378

Corneal ulcer

379

1.27

0.84

1.0

28.38

42.79

ng/l

2.49

265

Other pleural conditions

239

0.67

0.84

1.0

49.21

44.60

ng/l

—

142

Other and unspecified effects of external causes

505

1.23

0.84

1.0

43.68

43.79

ng/l

0.01

354

Benign neoplasm: Stomach

239

1.34

0.84

1.1

1.0

46.59

47.03

ng/l

0.02

147

Tinnitus

596

1.21

0.84

1.0

66.91

43.04

ng/l

0.43

417

Other hammer toe(s) (acquired)

471

0.78

0.84

1.1

1.0

48.73

46.60

ng/l

0.11

314

Antenatal screening

169

0.70

0.83

1.0

28.37

37.07

ng/l

1.33

139

Soft tissue disorders related to use, overuse and pressure

697

1.19

0.83

1.0

38.96

46.07

ng/l

0.62

483

Benign neoplasm of colon, rectum, anus and anal canal

214

1371

1.12

0.83

1.0

41.48

44.28

ng/l

0.33

153

941

Asthma

260

1261

1.11

0.83

1.0

47.47

42.49

ng/l

0.27

181

879

Diseases of appendix

183

1869

0.89

0.83

1.0

38.75

41.35

ng/l

0.48

138

1324

Dental pulpitis 1, only avohilmo

346

1656

1.09

0.83

1.0

41.88

41.34

ng/l

0.07

237

1147

Benign neoplasm of meninges

257

1.33

0.83

1.0

33.23

47.03

ng/l

1.46

162

L02BA Anti-estrogens

365

0.74

0.82

1.1

1.0

36.75

44.90

ng/l

0.71

248

Hydrocele

266

1.32

0.82

1.0

29.34

42.13

ng/l

2.40

168

Nummular dermatitis

197

1.37

0.82

1.0

34.67

46.17

ng/l

1.14

129

Nasal polyp

516

1.22

0.82

1.0

41.27

41.53

ng/l

0.02

348

Divergent concomitant strabismus

138

1.45

0.81

1.1

1.0

39.33

43.17

ng/l

0.18

Other symptoms and signs involving the circulatory and respiratory systems

138

1.45

0.81

1.0

67.43

45.02

ng/l

0.33

Non-follicular lymphoma, hilmo, excluding all cancers

272

0.70

0.81

1.0

44.00

47.45

ng/l

0.31

170

Benign neoplasm of other and unspecified endocrine glands

346

1.27

0.81

1.0

32.98

46.28

ng/l

2.01

227

Benign neoplasm: Cerebral meninges

241

1.33

0.80

1.0

33.86

47.94

ng/l

1.42

153

Urticaria

590

1.20

0.80

1.0

43.47

42.79

ng/l

0.05

415

Achilles tendinitis

241

1.33

0.80

1.0

39.97

45.22

ng/l

0.27

180

Enlarged lymph nodes

320

1.28

0.80

1.0

37.75

44.58

ng/l

0.82

234

Nonsuppurative otitis media

265

0.72

0.80

1.0

44.47

45.57

ng/l

0.05

170

Mycoses

631

0.81

0.79

1.0

40.15

43.71

ng/l

0.35

431

Carcinoid syndrome

0.00

0.79

0.0

1.0

—

36.18

—

Irregular menses

105

732

1.16

0.79

1.0

33.47

44.55

ng/l

1.99

536

Other and unspecified haemorrhagic conditions

0.00

0.79

0.0

1.0

—

33.55

—

Malignant neoplasm of heart, mediastinum and pleura

0.00

0.79

0.0

1.0

—

35.74

—

Failed induction of labour

0.00

0.79

0.0

1.0

—

44.22

—

Type 1 diabetes, wide definition, subgroup 2

0.00

0.79

0.0

1.0

—

34.64

—

Dissociative [conversion] disorders

1.82

0.79

1.0

33.50

48.13

ng/l

—

Venous thromboembolism

134

1480

0.88

0.79

1.0

37.28

43.09

ng/l

1.17

1000

Varus deformity, not elsewhere classified

0.00

0.78

0.0

1.0

—

66.47

—

Acquired absence of organs, not elsewhere classified

0.00

0.78

0.0

1.0

—

36.43

—

Carpal tunnel syndrome

192

1554

1.12

0.78

1.0

41.85

42.22

ng/l

0.04

138

1084

Atypical facial pain

1.53

0.78

1.0

48.06

46.46

ng/l

—

Other abnormal findings of blood chemistry

1.56

0.78

1.0

23.63

47.27

ng/l

—

Haemorrhage in early pregnancy

471

1.22

0.78

1.1

1.0

52.56

43.48

ng/l

0.96

341

Familial hypercholesterolemia

429

1.24

0.78

1.0

39.31

48.11

ng/l

0.75

276

Melanoma of uvea

0.00

0.77

0.0

1.0

—

40.70

—

Primary open-angle glaucoma

829

1.16

0.77

1.0

43.74

44.88

ng/l

0.11

540

Polymyalgia rheumatica

326

0.73

0.76

1.0

51.54

44.65

ng/l

0.33

208

Pulmonary eosinophilia, not elsewhere classified

0.00

0.76

0.0

1.0

—

38.57

—

Other interventions on the root canals of the tooth

0.00

0.76

0.0

1.0

—

39.19

—

Gonarthrosis [arthrosis of knee](FG)

285

1534

1.09

0.76

1.0

39.08

42.98

ng/l

0.86

196

1085

Sulfonylureas

856

0.86

0.75

1.0

41.55

45.91

ng/l

0.46

566

Injuries to the hip and thigh

132

1062

1.14

0.75

1.0

50.73

43.32

ng/l

0.64

714

Other protozoal intestinal diseases

2.09

0.74

1.2

1.0

34.80

30.15

ng/l

—

L02BB Anti-androgens

220

0.68

0.74

1.0

42.36

43.17

ng/l

—

137

Other disorders of veins

1100

0.86

0.74

1.0

43.43

43.34

ng/l

0.01

784

Sub-endpoint used in defining T1D endpoints

577

1.19

0.74

1.0

40.40

40.86

ng/l

0.04

396

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

312

0.74

1.0

29.78

48.69

ng/l

3.07

189

Iron deficiency anaemia secondary to blood loss (chronic)

369

0.76

0.74

1.0

48.18

43.83

ng/l

0.20

239

Postprocedural musculoskeletal disorders, not elsewhere classified

167

1.38

0.73

1.1

1.0

26.47

45.31

ng/l

2.84

104

Intestinal infectious diseases

268

1909

1.09

0.73

1.0

39.80

41.84

ng/l

0.39

200

1313

Injuries to the knee and lower leg

363

1923

1.08

0.73

1.0

37.36

42.75

ng/l

1.63

257

1335

Benign neoplasm: Sigmoid colon

551

1.20

0.73

1.0

34.21

45.69

ng/l

1.55

357

Lyme disease

653

1.18

0.72

1.1

1.0

43.73

44.14

ng/l

0.03

447

Endometriosis of rectovaginal septum and vagina

142

1.41

0.72

1.1

1.0

47.64

55.22

ng/l

0.29

Herpesviral [herpes simplex] infections

230

0.69

0.72

1.0

33.89

46.84

ng/l

—

153

Asthma (diagnoses ohter than nonallergic)

249

1946

1.09

0.72

1.0

48.20

41.00

ng/l

0.42

178

1348

Female infertility, cervigal, vaginal, other or unspecified origin

359

0.80

0.71

1.0

34.34

45.02

ng/l

1.75

260

Abnormalities of heart beat

850

1.16

0.71

1.0

38.09

47.09

ng/l

1.26

566

Atopic dermatitis, strict definition

390

1.23

0.71

1.0

33.12

43.17

ng/l

1.81

270

Persons encountering health services for specific procedures, not carried out

134

1.42

0.71

1.0

31.77

47.49

ng/l

1.06

Malignant melanoma of skin

287

0.73

0.71

1.0

34.36

44.13

ng/l

0.64

188

Benign neoplasm of major salivary glands

264

0.72

0.71

1.1

1.0

52.00

45.69

ng/l

0.17

167

ILD medications

309

1839

0.92

0.71

1.0

38.64

40.90

ng/l

0.48

212

1293

Alcoholic gastritis

1.93

0.71

1.2

1.0

42.20

31.36

ng/l

—

COPD/asthma/ILD related infections

343

1588

1.08

0.70

1.0

41.52

43.00

ng/l

0.09

236

1117

COPD/asthma related infections

343

1588

1.08

0.70

1.0

41.52

43.00

ng/l

0.09

236

1117

Lateral epicondylitis

309

1.26

0.70

1.0

43.07

42.47

ng/l

0.03

219

Other and unspecified urticaria

381

1.23

0.70

1.0

39.29

45.32

ng/l

0.57

256

Maltreatment syndromes

1.71

0.70

1.1

1.0

49.71

34.32

ng/l

—

Melanoma in situ of other and unspecified parts of face

1.86

0.68

1.0

33.80

35.89

ng/l

—

UC patients in KELA-register (code 208), prior to 1994

110

1.46

0.68

1.1

1.0

50.50

45.07

ng/l

—

Polyarthrosis

559

1.18

0.68

1.0

39.90

45.47

ng/l

0.61

380

Other joint disorders

255

1243

1.09

0.68

1.0

40.22

41.35

ng/l

0.17

181

877

Polyarthropathies

204

1233

1.10

0.68

1.0

39.64

41.47

ng/l

0.31

143

870

Noninfectious colitis NAS

266

1.28

0.68

1.0

26.25

46.07

ng/l

6.34

174

Conjunctivitis (acute, non atopic)

536

1.19

0.67

1.0

39.18

42.60

ng/l

0.14

370

Malignant neoplasm of breast, HER-negative

518

0.81

0.67

1.0

48.19

45.41

ng/l

0.17

349

Other spirochaetal diseases

658

1.17

0.67

1.1

1.0

43.73

44.03

ng/l

0.02

449

Crohn's disease NAS

102

1.47

0.67

1.0

40.73

43.32

ng/l

0.08

Insulin, fast-acting

853

1.15

0.67

1.0

42.95

42.08

ng/l

0.08

586

Seropositive rheumatoid arthritis, strict definition

374

0.77

0.67

1.0

46.35

45.65

ng/l

0.03

247

L04AA Selective immunosuppressants

496

0.81

0.67

1.0

46.98

44.07

ng/l

0.16

348

Fracture of lower leg, including ankle

164

1470

1.11

0.67

1.0

37.64

43.39

ng/l

1.07

111

1020

Ankylosing spondylitis

179

1.34

0.66

1.0

37.49

45.33

ng/l

0.67

129

Otalgia

136

1.40

0.66

1.0

48.27

43.97

ng/l

0.18

Asthma (only as main-diagnosis), excluding more controls

224

1217

1.10

0.66

1.0

50.98

42.52

ng/l

0.41

148

850

Viral warts

179

0.67

0.66

1.0

46.71

44.61

ng/l

—

113

Type 1 diabetes, wide definition

420

1.21

0.66

1.0

41.51

42.77

ng/l

0.09

289

Asthma, hospital admissions , main diagnosis only

232

1903

1.09

0.66

1.0

50.32

40.93

ng/l

0.50

153

1334

Chronic ulcer of skin, not elsewhere classified

155

0.64

0.65

1.1

1.0

43.80

44.71

ng/l

—

Female infertility

368

0.82

0.65

1.0

33.72

45.10

ng/l

1.99

266

Adhesive capsulitis of shoulder

430

1.21

0.65

1.0

48.32

43.90

ng/l

0.29

301

Dermatitis due to substances taken internally

103

1.46

0.65

1.1

1.0

25.60

48.16

ng/l

—

Other specified and unspecified personality disorders

154

1.37

0.65

1.0

32.27

43.39

ng/l

1.18

Coagulation defects, purpura and other haemorrhagic conditions

394

0.79

0.64

1.0

44.15

44.38

ng/l

0.01

263

Coronary angioplasty

107

933

0.88

0.64

1.0

40.52

43.17

ng/l

0.27

637

Other diseases of upper respiratory tract

357

1733

1.07

0.64

1.0

42.15

42.12

ng/l

0.00

251

1199

Melanoma in situ of other and unspecified parts of face

1.73

0.64

1.0

33.80

33.33

ng/l

—

Insulin, fast-acting or short human

867

1.14

0.63

1.0

42.86

41.57

ng/l

0.12

589

Other infective otitis externa

129

1.40

0.63

1.0

39.39

44.39

ng/l

0.28

Malignant neoplasm of head and neck

200

0.70

0.63

1.0

34.78

44.47

ng/l

—

128

Cholelithiasis, broad definition with cholecystitis

245

1822

0.92

0.62

1.0

50.76

41.10

ng/l

0.53

154

1275

Benign neoplasm of major salivary glands

257

0.74

0.62

1.1

1.0

52.00

45.56

ng/l

0.18

168

Other and unspecified visual disturbances

199

1.31

0.62

1.0

25.21

45.47

ng/l

3.20

126

Other/unspecified seropositive rheumatoid arthritis

708

0.85

0.62

1.0

43.46

44.35

ng/l

0.06

477

Primary_lymphoid and hematopoietic malignant neoplasms

643

0.84

0.62

1.1

1.0

38.72

42.75

ng/l

0.41

422

Other disorders of bone

415

1.21

0.62

1.0

35.95

44.24

ng/l

1.14

294

Special screening examination for neoplasms

1.59

0.61

1.2

1.0

49.54

48.47

ng/l

—

Injury of muscle and tendon at lower leg level

380

0.79

0.61

1.0

39.23

43.59

ng/l

0.27

262

Corneal degeneration

1.67

0.61

1.0

49.20

37.59

ng/l

—

Other sexually transmitted chlamydial diseases

1.67

0.61

1.0

20.20

31.28

ng/l

—

Diseases of middle ear and mastoid

904

0.88

0.61

1.0

43.02

41.17

ng/l

0.18

617

Cellulitis

498

1.19

0.61

1.0

44.68

43.26

ng/l

0.09

342

Chronic lower respiratory diseases

373

1886

1.07

0.61

1.0

43.37

41.20

ng/l

0.15

260

1320

Seropositive rheumatoid arthritis, wide

717

0.85

0.60

1.0

43.26

44.24

ng/l

0.07

483

Ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

0.00

0.60

0.0

1.0

—

44.10

—

Cardiomyopathies, Secondary/extrinsic

0.00

0.60

0.0

1.1

—

37.10

—

Carcinoma in situ of breast, lobular

0.00

0.60

0.0

1.0

—

60.11

—

Other congenital malformations of upper alimentary tract

0.00

0.60

0.0

1.1

—

34.03

—

Other and unspecified aplastic anaemias

0.00

0.60

0.0

1.1

—

36.50

—

Tooth agenesis EXCLUDE clefts and syndromes

0.00

0.60

0.0

1.1

—

37.25

—

Ductal carcinoma of pancreas

0.00

0.60

0.0

1.0

—

35.43

—

Malignant neoplasm of other and unspecified major salivary glands, excluding all cancers (controls excluding all cancers)

0.00

0.60

0.0

1.0

—

39.88

—

Malignant neoplasm of bone and articular cartilage of limbs, excluding all cancers (controls excluding all cancers)

0.00

0.60

0.0

1.0

—

37.02

—

ILD, hospital admission 2, with pulmonary infections

221

0.72

0.60

1.0

30.75

47.45

ng/l

—

145

Inflammatory bowel disease

685

1.15

0.60

1.0

32.90

42.32

ng/l

1.79

485

Leiomyosarcoma, excluding all cancers (controls excluding all cancers)

0.00

0.59

0.0

1.0

—

41.92

—

Benign neoplasm: Short bones of lower limb

0.00

0.59

0.0

1.0

—

43.31

—

Carcinoma in situ of skin of ear and external auricular canal

0.00

0.59

0.0

1.0

—

34.44

—

Bell's palsy

272

1.25

0.59

1.0

40.93

43.75

ng/l

0.20

185

Hypoparathyroidism

1.53

0.59

1.0

25.00

51.75

ng/l

—

Benign neoplasm: Rectum

491

1.18

0.59

1.0

43.44

44.51

ng/l

0.08

331

Unspecified haematuria

129

990

1.12

0.59

1.0

43.96

41.84

ng/l

0.25

663

Melanoma of uvea

0.00

0.58

0.0

1.0

—

41.44

—

Combined immunodeficiencies

0.00

0.58

0.0

1.0

—

33.11

—

Other diseases of oesophagus

210

1.29

0.58

1.0

31.84

43.04

ng/l

1.00

129

Dissocial personality disorder

0.00

0.58

0.0

1.0

—

28.88

—

Accidental poisoning by and exposure to alcohol

0.00

0.58

0.0

1.0

—

34.30

—

Gastroduodenal ulcer

657

1.15

0.58

1.0

40.31

44.39

ng/l

0.46

431

Ovarian cyst

449

1.15

0.58

1.0

42.29

44.35

ng/l

0.18

313

Bronchitis

281

1982

0.93

0.58

1.0

35.78

42.77

ng/l

2.57

191

1382

Corns and callosities

149

1.34

0.57

1.1

1.0

43.00

42.85

ng/l

—

Infections of the skin and subcutaneous tissue

151

1362

1.10

0.57

1.0

38.16

40.68

ng/l

0.36

107

948

Seropositive rheumatoid arthritis

711

0.86

0.57

1.0

43.26

47.07

ng/l

0.29

473

Asthma (only as main-diagnosis)

227

1261

1.09

0.57

1.0

50.94

42.49

ng/l

0.42

149

879

Benign neoplasm: Adrenal gland

193

1.30

0.57

1.0

36.47

46.02

ng/l

0.69

119

COPD differential diagnosis

272

1263

1.08

0.57

1.0

39.22

42.45

ng/l

0.73

199

880

ILD differential diagnosis

272

1263

1.08

0.57

1.0

39.22

42.45

ng/l

0.73

199

880

Systemic connective tissue disorders

872

0.87

0.56

1.0

44.17

43.98

ng/l

0.02

582

Pollen allergy

200

1.29

0.56

1.0

41.49

41.16

ng/l

0.01

138

Burns and corrosions

275

0.76

0.56

1.1

1.0

36.29

43.24

ng/l

0.47

182

Spondylopathies (FG)

283

1.24

0.56

1.0

35.90

43.73

ng/l

0.93

202

Dentofacial anomalies [including malocclusion]

589

1.16

0.56

1.0

41.48

41.20

ng/l

0.02

424

Peripheral artery operations in Hilmo

308

0.78

0.56

1.0

38.13

44.68

ng/l

0.68

186

Ankylosing spondylitis, ICD10

185

1.30

0.56

1.0

37.49

42.22

ng/l

0.34

120

Spirochaetal infections, other/unspecified

194

1.29

0.55

1.1

1.0

41.48

47.01

ng/l

0.32

121

Benign neoplasm: Skin of upper limb, including shoulder

1.63

0.55

1.0

39.50

50.36

ng/l

—

Benign neoplasm: Skin of upper limb, including shoulder

1.63

0.55

1.0

39.50

34.81

ng/l

—

Diseases of pulp and periapical tissues

934

0.88

0.55

1.0

38.44

40.45

ng/l

0.22

657

Myeloproliferative diseases

206

0.73

0.55

1.0

38.10

46.88

ng/l

—

130

Prepatellar bursitis

107

1.41

0.55

1.0

25.00

49.30

ng/l

—

Preterm labour and delivery

541

1.17

0.55

1.0

35.90

41.17

ng/l

0.56

397

Benign neoplasm of eye and adnexa

251

0.76

0.55

1.0

44.81

47.33

ng/l

0.09

158

Benign neoplasms

228

1191

1.08

0.54

1.0

41.93

41.09

ng/l

0.10

168

826

Cholelithiasis

236

1785

0.93

0.54

1.0

50.94

41.30

ng/l

0.51

151

1244

Acne vulgaris

1.58

0.54

1.2

1.0

22.67

29.68

ng/l

—

Non-allergic asthma (mode)

492

1.17

0.53

1.0

43.11

45.94

ng/l

0.20

329

Injuries to the ankle and foot

148

1480

0.91

0.53

1.0

37.56

41.71

ng/l

0.61

112

1038

Dentinal caries

522

1.16

0.53

1.0

46.27

41.52

ng/l

0.38

357

Idiopathic gout

238

0.75

0.53

1.0

43.00

43.86

ng/l

—

149

Superficial injury of hip and thigh

304

1.22

0.52

1.0

60.57

43.43

ng/l

0.55

198

Other necrotizing vasculopathies (FG)

143

1.33

0.52

1.0

42.85

46.77

ng/l

0.17

Fracture of femur

539

1.15

0.52

1.1

1.0

43.94

45.03

ng/l

0.07

347

Non-allergic asthma (mode), excluding more controls

493

1.17

0.52

1.0

43.11

46.21

ng/l

0.23

327

Overexertion and strenuous or repetitive movements

214

1.26

0.52

1.0

28.80

44.99

ng/l

2.13

137

Amputation

226

0.75

0.52

1.0

41.25

45.32

ng/l

0.25

137

Polyarthritis, unspecified

1.45

0.52

1.0

32.47

45.39

ng/l

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

694

0.86

0.51

1.0

43.46

44.44

ng/l

0.07

470

Injury of muscle and tendon at wrist and hand level

305

1.21

0.51

1.0

34.41

41.96

ng/l

0.88

217

Other menopausal disorders

426

0.87

0.51

1.0

45.06

44.59

ng/l

0.03

302

463

0.84

0.51

1.0

48.21

46.01

ng/l

0.12

285

Diseases of the skin and subcutaneous tissue

330

1554

1.07

0.50

1.0

39.93

42.75

ng/l

0.54

220

1088

Other disorders of bone density and structure

1.47

0.50

1.2

1.0

31.67

36.47

ng/l

—

Unspecified misadventure during surgical and medical care

118

1.36

0.50

1.0

36.00

44.88

ng/l

—

Gout

699

0.87

0.50

1.0

38.11

42.69

ng/l

0.55

476

Arthropathies

262

1243

1.07

0.50

1.0

39.38

41.35

ng/l

0.34

188

877

Diseases of arteries, arterioles and capillaries (FINNGEN)

544

0.87

0.50

1.0

43.41

45.23

ng/l

0.15

402

Presence of cardiac and vascular implants and grafts

129

1075

0.91

0.49

1.0

38.68

42.41

ng/l

0.65

713

Covid-19 suspected case

343

1.20

0.49

1.0

37.05

43.11

ng/l

0.54

238

Temporomandibular joint disorders, including avohilmo

772

1.13

0.49

1.0

36.88

42.78

ng/l

0.99

552

Non-follicular lymphoma

246

0.77

0.49

1.0

44.00

44.77

ng/l

0.06

159

Other noninflammatory disorders of uterus, except cervix

414

0.86

0.49

1.0

52.40

45.24

ng/l

0.73

286

Gastric ulcer

436

1.17

0.49

1.0

37.59

44.39

ng/l

0.72

276

Hydronephrosis

257

0.78

0.49

1.0

52.00

44.74

ng/l

0.42

162

Obstructed labour due to maternal pelvic abnormality

353

1.19

0.49

1.0

41.83

42.41

ng/l

0.03

256

Gestational diabetes (for exclusion)

253

0.81

0.49

1.0

30.20

42.03

ng/l

1.66

195

Scleritis and episcleritis

110

1.37

0.48

1.1

1.0

42.84

44.38

ng/l

—

Varicose veins of other sites

145

1.31

0.48

1.0

30.33

45.63

ng/l

1.68

Other benign neoplasms of skin

1071

0.90

0.48

1.1

1.0

43.66

46.21

ng/l

0.23

720

Other viral diseases

491

1.16

0.48

1.0

37.12

40.33

ng/l

0.26

351

Diabetic retinopathy

505

1.13

0.48

1.0

32.00

38.71

ng/l

1.28

344

Misadventures to patients during surgical and medical care

326

1.20

0.48

1.0

33.20

44.03

ng/l

1.58

216

Arthropod-borne viral fevers and viral haemorrhagic fevers

234

0.77

0.48

1.1

1.0

28.42

43.58

ng/l

1.40

157

ILD, hospital admissions 3, with pneumonia sepsis

189

0.74

0.48

1.0

31.50

46.02

ng/l

—

120

Other symptoms and signs involving the urinary system

244

1.23

0.48

1.0

31.93

42.87

ng/l

1.59

158

IBD patients in KELA-register

456

1.16

0.47

1.0

36.71

42.75

ng/l

0.60

323

Other heart diseases, wide

291

1695

1.07

0.47

1.0

41.01

41.80

ng/l

0.12

204

1210

Cholecystectomy

188

1793

0.93

0.47

1.0

54.77

41.14

ng/l

0.61

120

1247

Ill-defined and unknown causes of mortality

137

1.32

0.47

1.0

26.28

42.47

ng/l

—

Allergic contact dermatitis

263

1.22

0.47

1.0

51.68

47.90

ng/l

0.17

176

All influenza (not pneumonia)

318

1.20

0.46

1.1

1.0

31.23

43.87

ng/l

2.52

218

Heartburn

227

1.23

0.46

1.1

1.0

31.95

43.30

ng/l

1.67

154

Other peripheral vascular diseases

173

1.27

0.46

1.0

42.43

44.91

ng/l

0.12

103

Toxic effects of substances chiefly nonmedicinal as to source

218

1.24

0.46

1.0

40.14

46.70

ng/l

0.48

142

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

200

1.25

0.46

1.0

31.92

47.70

ng/l

1.47

124

Other disorders of white blood cells

117

0.68

0.46

1.0

36.00

43.90

ng/l

—

Presence of other devices

570

1.14

0.45

1.1

1.0

47.69

44.13

ng/l

0.30

355

Other systemic involvement of connective tissue

643

0.87

0.45

1.0

44.32

44.95

ng/l

0.04

434

Melanocytic naevi of trunk

254

0.79

0.45

1.0

34.53

46.93

ng/l

1.16

164

Dislocation, sprain and strain of joints and ligaments at neck level

246

1.22

0.45

1.0

34.86

45.05

ng/l

0.82

165

Other disorders of breast

237

1.22

0.45

1.1

1.0

102.05

46.06

ng/l

0.40

170

Other systemic involvement of connective tissue (FG)

638

0.87

0.45

1.0

44.32

45.05

ng/l

0.05

421

Deep endometriosis

156

1.28

0.45

1.1

1.0

47.64

47.56

ng/l

0.00

102

Superficial injury of forearm

156

1.28

0.45

1.0

32.88

42.73

ng/l

0.79

Fenamates

227

1.19

0.44

1.0

47.50

45.10

ng/l

0.12

157

Inflammatory bowel disease, strict (require KELA)

459

1.16

0.44

1.0

36.71

42.38

ng/l

0.55

329

Pilonidal cyst

112

1.34

0.44

1.0

23.67

37.36

ng/l

—

Varicose veins

186

1512

0.93

0.44

1.0

44.39

42.93

ng/l

0.20

123

1055

Other ill-defined and unspecified causes of mortality

121

1.32

0.44

1.0

27.64

44.35

ng/l

—

Pregnancy, childbirth and the puerperium

278

1.15

0.44

1.0

48.60

43.97

ng/l

0.25

176

Peritonsillar abscess

416

0.84

0.44

1.0

36.64

40.58

ng/l

0.29

294

Other/unspecified enthesopathies of lower limb, excluding foot

130

1.31

0.44

1.0

18.30

49.08

ng/l

—

Other inflammation of eyelid

284

1.20

0.43

1.0

36.59

46.61

ng/l

1.11

188

Acute appendicitis

174

1767

0.93

0.43

1.1

1.0

38.62

41.00

ng/l

0.41

130

1259

Complications of procedures, not elsewhere classified

240

1946

1.07

0.43

1.0

41.62

42.22

ng/l

0.09

169

1358

Lesion of ulnar nerve

340

1.18

0.43

1.0

43.38

41.99

ng/l

0.04

242

Dermatitis and eczema

322

1998

1.06

0.42

1.0

38.04

42.27

ng/l

1.14

228

1394

Personal history of other diseases and conditions

130

1.30

0.42

1.0

39.07

42.93

ng/l

0.16

Excluding asthma or asthma-COPD overlap

270

1272

1.06

0.42

1.0

39.38

42.39

ng/l

0.65

196

885

Other pulmonary diagnosis

270

1272

1.06

0.42

1.0

39.45

42.39

ng/l

0.63

194

885

Aplastic and other anaemias

107

1114

0.91

0.42

1.0

40.86

43.89

ng/l

0.38

728

Malignant neoplasm of bladder

162

0.74

0.42

1.0

44.71

41.84

ng/l

—

Benign neoplasm of eye and adnexa

240

0.79

0.42

1.0

44.81

45.08

ng/l

0.01

150

Delivery, wide proxy

339

1.13

0.42

1.0

48.32

44.92

ng/l

0.20

215

Disorders of calcium metabolism

131

1.30

0.42

1.0

31.33

47.80

ng/l

—

Other diseases of intestine

313

1.18

0.42

1.0

38.74

44.97

ng/l

0.74

214

Wet age-related macular degeneration

353

0.83

0.41

1.1

1.0

39.18

46.74

ng/l

0.48

213

Other necrotizing vasculopathies

158

1.27

0.41

1.0

41.43

45.14

ng/l

0.17

Abnormal serum enzyme levels

877

1.10

0.41

1.0

40.83

42.29

ng/l

0.14

586

Tobacco use

1.36

0.41

1.0

29.88

43.26

ng/l

—

Toxoplasmosis

0.00

0.41

0.0

1.1

—

37.25

—

Osteopathy in diseases classified elsewhere

0.00

0.41

0.0

1.1

—

40.43

—

Anuria and oliguria

0.00

0.41

0.0

1.0

—

36.33

—

Carcinoma in situ of breast, lobular

0.00

0.41

0.0

1.1

—

40.86

—

Disorders of plasma-protein metabolism, not elsewhere classified

0.00

0.41

0.0

1.1

—

33.81

—

Increased muscle tone

0.00

0.41

0.0

1.0

—

32.75

—

Other specified/unspecified nutritional deficiencies

0.00

0.41

0.0

1.1

—

35.00

—

Benign neoplasm: Bone and articular cartilage, unspecified

0.00

0.41

0.0

1.0

—

37.30

—

Other injuries of spine and trunk, level unspecified

0.00

0.41

0.0

1.1

—

33.50

—

Melanocytic naevi of lip

0.00

0.41

0.0

1.1

—

34.67

—

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

0.00

0.41

0.0

1.1

—

34.67

—

Striae atrophicae

0.00

0.41

0.0

1.1

—

44.22

—

Infarction of spleen

0.00

0.41

0.0

1.1

—

35.43

—

ILD medications: nintedanib

0.00

0.41

0.0

1.1

—

39.96

—

Bus occupant injured in other and unspecified transport accidents

0.00

0.41

0.0

1.1

—

38.60

—

Complications peculiar to reattachment and amputation

0.00

0.41

0.0

1.0

—

36.75

—

Lung transplant status

0.00

0.41

0.0

1.0

—

36.22

—

Lung transplantation

0.00

0.41

0.0

1.0

—

36.22

—

Other and unspecified disorders of pigmentation

0.00

0.41

0.0

1.1

—

33.81

—

Other injuries of lower limb, level unspecified

0.00

0.41

0.0

1.1

—

37.25

—

Myelodysplastic syndrome

0.00

0.41

0.0

1.0

—

37.67

—

Anomalies of dental arch relationship, including avohilmo

274

0.82

0.41

1.0

32.67

43.88

ng/l

0.92

190

Unspecified human immunodeficiency virus [HIV] disease

0.00

0.41

0.0

1.0

—

27.00

—

Arthropathy in Crohn disease

0.00

0.41

0.0

1.1

—

39.00

—

Paget disease

0.00

0.41

0.0

1.1

—

36.90

—

Bacterial pneumonia (organism specified)

102

1020

0.91

0.41

1.0

30.47

43.10

ng/l

6.54

680

Osteitis due to dental implant

0.00

0.41

0.0

1.1

—

38.00

—

Fibrosis of liver

0.00

0.41

0.0

1.1

—

44.79

—

Leiomyosarcoma

0.00

0.41

0.0

1.1

—

40.56

—

Aspergillosis

0.00

0.41

0.0

1.0

—

36.13

—

Complications following myocardial infarction

0.00

0.41

0.0

1.1

—

44.22

—

Blindness, monocular

0.00

0.41

0.0

1.1

—

36.26

—

Other and unspecified acquired haemolytic anaemias

0.00

0.41

0.0

1.1

—

35.03

—

Other and unspecified acne

0.00

0.40

0.0

1.0

—

35.90

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

0.00

0.40

0.0

1.0

—

33.25

—

Use of glatiramer acetate

0.00

0.40

0.0

1.0

—

33.91

—

Polycystic ovarian syndrome

0.00

0.40

0.0

1.1

—

43.10

—

Infections with a predominantly sexual mode of transmission

463

1.14

0.40

1.0

35.28

42.45

ng/l

0.93

324

Other and unspecified vascular occlusions

213

1.22

0.40

1.0

31.50

43.15

ng/l

1.29

132

Diseases of external ear

824

1.10

0.40

1.0

37.08

42.86

ng/l

0.92

565

Atlantoaxial subluxation

0.00

0.40

0.0

1.1

—

43.75

—

Polyarteritis nodosa

0.00

0.40

0.0

1.0

—

39.43

—

Cervical root disorders

0.00

0.40

0.0

1.1

—

39.00

—

Malignant neoplasm of other and unspecified urinary organs, excluding all cancers (controls excluding all cancers)

0.00

0.40

0.0

1.0

—

36.02

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

0.00

0.40

0.0

1.0

—

41.92

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

0.00

0.40

0.0

1.1

—

35.67

—

Malignant neoplasm of parotid gland

0.00

0.40

0.0

1.1

—

34.43

—

Malignant neoplasm of eye and adnexa

0.00

0.40

0.0

1.1

—

40.48

—

Use of entacapone

0.00

0.40

0.0

1.1

—

36.53

—

Acute mastoiditis

0.00

0.40

0.0

1.1

—

43.50

—

Benign neoplasm: Short bones of lower limb

0.00

0.40

0.0

1.1

—

41.30

—

Migraine without aura, drug-induced

0.00

0.40

0.0

1.1

—

32.64

—

Nail disorders

150

1.27

0.40

1.1

1.0

29.39

42.12

ng/l

0.88

Use of cabergoline

0.00

0.40

0.0

1.0

—

38.04

—

Assault by sharp object

0.00

0.40

0.0

1.0

—

29.45

—

Abrasion of teeth

486

1.12

0.40

1.0

59.58

43.93

ng/l

0.28

346

Other (seronegative) rheumatoid arthritis, wide

465

0.86

0.40

1.0

42.07

44.94

ng/l

0.17

316

Congenital malformations of great arteries

0.00

0.40

0.0

1.1

—

40.75

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

677

0.89

0.39

1.1

1.0

31.43

43.03

ng/l

1.38

484

Urticaria and erythema

758

1.11

0.39

1.0

41.92

42.58

ng/l

0.06

530

Benign neoplasm: Stomach

269

1.19

0.39

1.1

1.0

46.59

46.86

ng/l

0.01

171

Disturbances of skin sensation

559

1.13

0.39

1.0

64.30

43.11

ng/l

0.32

396

Diagnoses used for exclusion with ILD

635

1.12

0.39

1.0

43.47

42.88

ng/l

0.05

425

Chronic periapical parodontitis

528

0.87

0.39

1.0

41.32

42.07

ng/l

0.05

360

Benign neoplasm: Adrenal gland

205

1.22

0.39

1.0

36.47

48.17

ng/l

0.91

130

Acute drug-induced interstitial lung disorder

0.00

0.39

0.0

1.0

—

38.63

—

Glaucoma secondary to eye inflammation

0.00

0.39

0.0

1.1

—

39.00

—

Intracranial and intraspinal abscess and granuloma

0.00

0.39

0.0

1.0

—

39.63

—

Traumatic amputation of wrist and hand

106

1.32

0.39

1.0

46.75

40.67

ng/l

—

Benign lipomatous neoplasm

778

1.11

0.39

1.0

37.02

42.68

ng/l

0.93

533

Certolizumab pegol

0.00

0.39

0.0

1.0

—

43.17

—

Delivery

460

1.10

0.39

1.0

44.68

43.71

ng/l

0.07

311

Disorders of mineral metabolism

187

1.23

0.39

1.0

28.23

49.27

ng/l

3.09

119

Other disorders of optic [2nd] nerve and visual pathways

115

1.31

0.38

1.0

47.10

45.29

ng/l

—

Acute bronchitis

909

0.90

0.38

1.0

35.70

42.96

ng/l

1.28

602

Ulcerative rectosigmoiditis

169

1.24

0.38

1.0

37.56

45.11

ng/l

0.59

110

Gonarthrosis,primary

318

1900

1.05

0.38

1.0

41.20

42.12

ng/l

0.15

212

1344

Chronic rhinitis, nasopharyngitis and pharyngitis

770

1.10

0.38

1.0

43.38

43.75

ng/l

0.02

537

Lung diseases due to external agents

298

1.18

0.38

1.0

41.11

45.45

ng/l

0.29

192

Pregnancy hypertension

722

0.90

0.38

1.1

1.0

42.69

43.92

ng/l

0.09

531

Undetermined asthma

312

0.83

0.38

1.0

53.48

46.28

ng/l

0.29

209

Entropion and trichiasis of eyelid

192

0.78

0.38

1.1

1.0

36.11

46.31

ng/l

—

114

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

206

1.22

0.38

1.0

31.92

51.13

ng/l

1.97

133

Thyroiditis, ILD-related definition

206

1.21

0.37

1.0

46.98

46.00

ng/l

0.03

146

Other metabolic disorders

243

1.19

0.37

1.0

35.33

48.56

ng/l

1.02

157

Stenosis and insufficiency of lacrimal passages

188

1.22

0.37

1.1

1.0

34.33

47.38

ng/l

1.55

121

Rheumatoid arthritis, including avohilmo

1040

0.91

0.37

1.0

39.70

43.19

ng/l

0.43

698

Non-allergic asthma

188

1.22

0.37

1.0

54.36

48.87

ng/l

0.20

117

Other diseases of anus and rectum

742

1.10

0.37

1.0

37.52

44.44

ng/l

1.11

500

Atopic dermatitis, strict definition with reimbursement

435

1.14

0.37

1.0

33.19

42.67

ng/l

1.78

312

Demyelinating diseases of the central nervous system

134

1.27

0.36

1.2

1.0

26.32

42.08

ng/l

2.35

Single spontaneous delivery

460

1.10

0.36

1.0

44.93

43.71

ng/l

0.08

311

AV-block

457

0.87

0.36

1.0

37.70

45.53

ng/l

0.88

279

Other disorders of prostate

1.36

0.36

1.0

27.17

43.70

ng/l

—

Chalazion

244

1.19

0.36

1.1

1.0

42.80

47.21

ng/l

0.21

163

Complications of medical and surgical care

214

1916

1.06

0.36

1.0

37.19

42.64

ng/l

1.58

156

1322

Disorders of vitreous body and globe

165

1505

1.07

0.36

1.0

47.09

43.26

ng/l

0.47

114

1045

Pedal cyclist injured in noncollision transport accidents

226

1.20

0.35

1.0

40.55

47.27

ng/l

0.38

146

Direct fill therapy

288

0.83

0.35

1.0

36.32

46.84

ng/l

1.00

192

Biomechanical lesions, not elsewhere classified

1.32

0.35

1.0

27.86

46.65

ng/l

—

Exposure to other specified factors

201

1776

1.06

0.35

1.0

43.94

40.92

ng/l

0.37

154

1239

Superficial injury of wrist and hand

338

1.15

0.35

1.0

39.02

44.79

ng/l

0.40

235

Haemorrhoids and perianal venous thrombosis

765

1.10

0.34

1.0

40.54

44.54

ng/l

0.39

508

Ectopic pregnancy

373

0.86

0.34

1.0

38.35

41.21

ng/l

0.23

274

Benign neoplasm: Parotid gland

200

0.80

0.34

1.1

1.0

55.80

47.80

ng/l

—

128

Injuries to unspecified part of trunk, limb or body region

189

0.79

0.34

1.0

47.94

45.04

ng/l

—

117

Separation of retinal layers (serosa)

1.32

0.33

1.1

1.0

34.00

38.53

ng/l

—

Paralytic ileus and intestinal obstruction

652

1.10

0.33

1.0

36.52

44.07

ng/l

1.17

440

Glucosamine medication

169

1266

1.07

0.33

1.0

54.70

43.48

ng/l

0.42

110

864

Spondyloarthritis

368

1.14

0.33

1.0

33.33

43.79

ng/l

1.74

259

Problems related to lifestyle

191

1.21

0.33

1.0

39.06

46.49

ng/l

0.61

125

Undetermined asthma, excluding more controls

307

0.85

0.33

1.0

53.48

46.68

ng/l

0.27

205

Obesity, other/unspecified

730

0.90

0.33

1.0

33.28

40.91

ng/l

1.23

519

Azathioprine

312

1.15

0.33

1.0

40.27

44.35

ng/l

0.23

220

Hernia of abdominal wall

115

1239

0.93

0.33

1.0

42.33

41.75

ng/l

0.03

849

Other acute lower respiratory infections

110

1133

0.93

0.33

1.0

35.60

42.18

ng/l

1.26

769

Impacted cerumen

219

1.19

0.33

1.0

30.07

44.61

ng/l

1.69

140

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

663

1.10

0.33

1.0

40.66

42.55

ng/l

0.16

462

Hypertrophy of breast in women and men

397

1.13

0.32

1.0

39.20

41.19

ng/l

0.11

270

Phlebitis and thrombophlebitis (not including DVT)

561

0.89

0.32

1.0

33.93

43.50

ng/l

1.70

392

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

238

1.18

0.32

1.0

34.17

46.75

ng/l

1.69

165

Obstructed labour due to malposition and malpresentation of fetus

268

1.16

0.32

1.0

39.26

38.67

ng/l

0.02

211

Excessive attrition of teeth

494

1.09

0.32

1.0

39.22

43.78

ng/l

0.63

348

Trigger finger

341

1.14

0.32

1.1

1.0

37.01

44.31

ng/l

0.61

238

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

127

749

1.08

0.32

1.0

37.55

43.10

ng/l

1.14

563

ILD medications: azathioprine

313

1.15

0.32

1.0

40.27

43.55

ng/l

0.18

216

Endometriosis ASRM stages 3,4

417

1.13

0.31

1.0

48.39

44.09

ng/l

0.26

289

Other and unspecified dermatitis

142

1330

1.07

0.31

1.0

34.80

43.07

ng/l

2.01

921

Diseases of the digestive system

121

1124

1.07

0.31

1.0

34.66

43.30

ng/l

1.70

751

Recurring oral aphthae, including avohilmo

284

0.84

0.31

1.0

46.92

45.42

ng/l

0.07

180

Coeliac disease

248

1.17

0.31

1.0

26.43

45.31

ng/l

4.68

165

Benign neoplasm: Tongue

1.35

0.31

1.1

1.0

14.71

50.96

ng/l

—

Rash and other nonspecific skin eruption

208

0.82

0.31

1.1

1.0

51.25

45.56

ng/l

0.22

135

Preparatory care for dialysis

0.73

0.31

1.0

63.71

40.89

ng/l

—

Complications predominantly related to the puerperium

437

1.12

0.31

1.0

73.03

42.80

ng/l

0.40

314

Short Achilles tendon (acquired)

1.32

0.31

1.3

1.0

30.00

46.20

ng/l

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

352

1.14

0.30

1.0

40.33

43.77

ng/l

0.21

253

Dermatitis

173

1633

1.06

0.30

1.0

35.27

42.96

ng/l

2.29

117

1134

Asthma-related pneumonia

829

1.08

0.30

1.0

62.35

43.02

ng/l

0.36

551

Calculus of kidney and ureter

798

0.91

0.30

1.0

38.09

42.19

ng/l

0.37

546

Plantar fascial fibromatosis

212

1.18

0.30

1.0

37.09

45.13

ng/l

0.83

140

Inguinal hernia, bilateral

268

1.16

0.30

1.0

35.36

41.94

ng/l

0.44

176

Other septicaemia

900

1.08

0.30

1.0

38.53

43.57

ng/l

0.88

604

Other arrhythmias

191

1543

0.95

0.30

1.0

40.38

43.18

ng/l

0.44

128

1091

Asthma, hospital admissions 3, pneumonia

830

1.08

0.29

1.0

62.35

42.96

ng/l

0.36

552

Asthma-related pneumonia or sepsis

830

1.08

0.29

1.0

62.35

42.96

ng/l

0.36

552

Other female pelvic inflammatory diseases

344

1.13

0.29

1.0

39.87

45.77

ng/l

0.42

237

Vitamin B12 deficiency anaemia

250

1.16

0.29

1.1

1.0

28.53

44.85

ng/l

1.72

156

Other and unspecified iron deficiency

744

0.91

0.29

1.0

43.67

44.30

ng/l

0.04

489

Other bacterial intestinal infections

401

1.12

0.29

1.0

37.97

45.43

ng/l

0.94

265

Benign neoplasm: Colon

179

1298

1.06

0.29

1.0

40.60

44.77

ng/l

0.45

123

886

Codeine

292

1536

1.04

0.29

1.0

41.63

43.33

ng/l

0.09

202

1067

Secondary hypertension

174

1.20

0.29

1.1

1.0

37.64

47.01

ng/l

0.46

119

Injury of eye and orbit

269

1.15

0.29

1.0

39.45

44.91

ng/l

0.40

184

Erysipelas

167

1440

1.06

0.29

1.0

36.18

42.23

ng/l

1.58

104

991

Other symptoms and signs involving the digestive system and abdomen

354

1.13

0.29

1.0

42.86

44.40

ng/l

0.11

233

Coxarthrosis

177

1136

1.06

0.28

1.0

38.37

41.87

ng/l

0.59

117

797

Congenital malformations of heart and great arteries

220

0.84

0.28

1.0

31.43

44.79

ng/l

1.83

145

Otitis externa

478

1.11

0.28

1.0

39.60

43.89

ng/l

0.41

334

Asthma, including avohilmo

348

1945

1.04

0.28

1.0

45.22

40.94

ng/l

0.31

235

1367

Complications of labour and delivery

141

836

0.94

0.28

1.0

54.84

41.87

ng/l

0.46

102

605

Triptan medication for migraine, min. 3 purchases

106

897

0.93

0.28

1.0

37.23

42.52

ng/l

0.68

661

Uterine polyps

216

0.83

0.28

1.0

29.74

47.46

ng/l

1.98

154

Other contact dermatitis

158

1.20

0.28

1.1

1.0

39.92

47.15

ng/l

0.32

100

Ulcerative colitis

536

1.10

0.28

1.0

31.38

43.86

ng/l

3.20

372

Other specified/unspecified hearing loss

186

1.18

0.28

1.1

1.0

37.24

45.09

ng/l

0.67

116

Atopic dermatitis

120

959

1.07

0.27

1.0

38.96

42.76

ng/l

0.46

683

Codeine or tramadol medication

350

1866

1.04

0.27

1.0

41.17

42.37

ng/l

0.08

243

1298

Melanocytic naevi of trunk

237

0.84

0.27

1.0

34.53

45.87

ng/l

1.04

149

Opioids

305

1537

1.04

0.27

1.0

34.21

43.30

ng/l

5.15

220

1068

Benign neoplasm of ovary

403

1.12

0.27

1.0

79.40

45.67

ng/l

0.36

279

Disorders of vitreous body

160

1482

1.06

0.27

1.0

47.23

43.29

ng/l

0.48

113

1029

Benign neoplasm of bone and articular cartilage

172

0.81

0.27

1.0

17.61

45.72

ng/l

—

109

All dysplastic lesions of the cervix uteri

300

0.86

0.27

1.0

32.44

41.84

ng/l

1.12

222

Other noninflammatory disorders of vulva and perineum

150

0.80

0.27

1.0

45.14

51.07

ng/l

—

106

Dipeptidyl peptidase 4 (DPP-4) inhibitors

328

1.13

0.26

1.1

1.0

29.45

46.21

ng/l

2.88

218

Endometriosis of pelvic peritoneum

277

1.14

0.26

1.0

45.60

46.85

ng/l

0.04

200

Benign neoplasm of other and ill-defined parts of digestive system

452

1.11

0.26

1.0

43.80

45.28

ng/l

0.08

306

Major coronary heart disease event

231

1611

0.96

0.26

1.0

39.69

43.38

ng/l

0.68

147

1116

Seronegative rheumatoid arthritis

289

0.86

0.26

1.0

46.67

46.06

ng/l

0.02

200

Visual field defects

182

0.82

0.26

1.1

1.0

48.20

45.00

ng/l

—

114

Sarcoidosis

319

1.13

0.26

1.0

45.34

44.95

ng/l

0.02

217

Conductive hearing loss, unspecified

178

1.18

0.26

1.0

30.92

42.39

ng/l

1.51

117

Benign neoplasm: salivary glands, exclude unknown (D119)

214

0.84

0.26

1.1

1.0

55.80

46.95

ng/l

—

135

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

0.67

0.26

1.0

60.80

55.38

ng/l

—

Congenital malformations, deformations and chromosomal abnormalities

130

1174

1.06

0.26

1.0

40.05

39.97

ng/l

0.01

829

Chronic laryngitis and laryngotracheitis

367

1.12

0.25

1.0

44.96

43.20

ng/l

0.12

254

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

203

0.84

0.25

1.0

34.88

50.62

ng/l

0.70

133

Other skin changes

404

0.89

0.25

1.1

1.0

39.90

45.25

ng/l

0.45

266

Inguinal or femoral hernia, bilateral

273

1.14

0.25

1.0

35.36

42.09

ng/l

0.45

177

Missing teeth due to accident, extraction or parodontitis

298

0.87

0.25

1.0

47.24

43.83

ng/l

0.16

206

Lichen planus, including avohilmo

454

1.10

0.25

1.0

38.75

44.65

ng/l

0.52

313

Combinations of oral blood glucose lowering drugs

859

1.07

0.25

1.1

1.0

32.57

43.42

ng/l

2.48

601

Glomerular disorders in diseases classified elsewhere

266

0.86

0.24

1.0

50.76

43.37

ng/l

0.39

179

Superficial injury of ankle and foot

191

0.84

0.24

1.1

1.0

31.00

44.22

ng/l

—

121

Benign neoplasm: Skin of other and unspecified parts of face

276

0.87

0.24

1.0

36.72

46.64

ng/l

0.76

174

Other otitis externa (chronic)

133

1.20

0.24

1.0

21.22

44.36

ng/l

—

Lymphoid leukaemia

126

0.79

0.24

1.2

1.0

39.80

49.80

ng/l

—

Rosacea

236

1.14

0.24

1.0

49.12

45.92

ng/l

0.13

158

Other and unspecified disorders of white blood cells

0.73

0.24

1.0

29.33

39.52

ng/l

—

Iron deficiency anaemia

973

0.94

0.24

1.0

46.08

43.66

ng/l

0.22

644

ILD medications: prednisolone, methylprednisolone, prednisone

314

1838

0.96

0.24

1.0

45.06

40.92

ng/l

0.27

217

1292

Noninflammatory disorders of female genital tract

449

0.93

0.23

1.0

43.65

44.35

ng/l

0.06

313

Contact with machinery

286

0.87

0.23

1.0

45.34

40.82

ng/l

0.22

201

Hallux valgus (acquired)

109

742

1.06

0.23

1.0

48.75

43.40

ng/l

0.50

510

Benign neoplasm: Rectum, anus and anal canal

552

1.09

0.23

1.0

51.17

44.39

ng/l

0.34

359

Other peripheral vertigo

222

0.86

0.23

1.1

1.0

41.21

45.06

ng/l

0.26

138

Other anaemias

101

1036

0.94

0.23

1.0

42.07

43.48

ng/l

0.15

681

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

1.32

0.23

1.0

35.20

62.96

ng/l

—

Urolithiasis

878

0.93

0.23

1.0

37.52

42.49

ng/l

0.52

599

Pre-eclampsia

338

0.89

0.23

1.1

1.0

45.49

43.16

ng/l

0.12

245

Maternal care for known or suspected abnormality of pelvic organs

190

0.87

0.23

1.0

35.31

42.60

ng/l

0.49

143

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

162

1.17

0.22

1.1

1.0

36.31

46.17

ng/l

0.69

101

Ventral hernia

598

0.92

0.22

1.1

1.0

41.20

44.53

ng/l

0.23

414

Rheumatoid arthritis

844

0.94

0.22

1.0

41.73

43.40

ng/l

0.16

578

LSIL lesion of the cervix uteri, vagina or vulva

181

1.16

0.22

1.0

32.07

46.02

ng/l

1.43

135

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

337

0.89

0.22

1.0

40.70

45.58

ng/l

0.31

227

Other arthritis (FG)

814

0.93

0.22

1.0

39.96

43.09

ng/l

0.34

554

Benign neoplasm: Vulva

1.22

0.22

1.0

76.80

56.61

ng/l

—

Allergic purpura

1.22

0.22

1.0

32.00

35.08

ng/l

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

326

0.89

0.22

1.1

1.0

34.70

44.35

ng/l

0.98

216

Care involving dialysis

178

0.84

0.22

1.0

53.76

43.40

ng/l

—

112

Open wound of wrist and hand

105

981

1.06

0.22

1.0

36.04

40.03

ng/l

0.80

682

Benign neoplasm: Ciliary body

0.00

0.21

0.0

1.0

—

36.00

—

Benign neoplasm: Ciliary body

0.00

0.21

0.0

1.1

—

36.00

—

Cytomegaloviral hepatitis

0.00

0.21

0.0

1.0

—

35.20

—

Biliary cirrhosis, NAS

0.00

0.21

0.0

1.1

—

37.20

—

Other degenerative disorders of eyelid and periocular area

0.00

0.21

0.0

1.1

—

37.40

—

Malignant neoplasm of other and unspecified major salivary glands

0.00

0.21

0.0

1.0

—

48.83

—

Toxic colitis

0.00

0.21

0.0

1.0

—

43.33

—

Malignant neoplasm of thymus

0.00

0.21

0.0

1.0

—

32.26

—

Abnormal findings in peritoneal fluid saliva

0.00

0.21

0.0

1.0

—

37.83

—

Crushing injury of ankle and foot

0.00

0.21

0.0

1.0

—

38.40

—

Malignant neoplasm of hypopharynx

0.00

0.21

0.0

1.0

—

30.46

—

Malignant neoplasm of gum

0.00

0.21

0.0

1.1

—

41.60

—

Systemic disorders of connective tissue in diseases classified elsewhere

0.00

0.21

0.0

1.0

—

44.17

—

Drowning and submersion while in natural water

0.00

0.21

0.0

1.0

—

34.80

—

Neuroendocrine tumor and carcinoma of stomach

0.00

0.21

0.0

1.1

—

41.83

—

Malignant neoplasm of accessory sinuses, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.0

—

39.38

—

Congenital malformations of oesophagus

0.00

0.21

0.0

1.0

—

29.00

—

Systemic sclerosis, icd10

1.19

0.21

1.0

57.40

52.33

ng/l

—

Severe visual impairment, binocular

0.00

0.21

0.0

1.1

—

47.60

—

Perforation of oesophagus

0.00

0.21

0.0

1.0

—

35.06

—

Internal derangement of knee

109

1028

1.06

0.21

1.0

33.78

41.81

ng/l

1.83

724

Deaf mutism, not elsewhere classified

0.00

0.21

0.0

1.0

—

38.66

—

Juvenile Open Angle Glaucoma

0.00

0.21

0.0

1.0

—

35.20

—

Acute myringitis

0.00

0.21

0.0

1.1

—

44.33

—

Diastasis of muscle

0.00

0.21

0.0

1.0

—

32.40

—

Other specified congenital malformation syndromes affecting multiple systems

0.00

0.21

0.0

1.1

—

31.83

—

Nezelof syndrome

0.00

0.21

0.0

1.1

—

29.19

—

Other/unspecified mastoiditis and related conditions

0.00

0.21

0.0

1.1

—

38.00

—

Renal agenesis and other reduction defects of kidney

0.00

0.21

0.0

1.1

—

33.50

—

Other dermatomyositis

0.00

0.21

0.0

1.1

—

41.00

—

Benign neoplasm: Retina

0.00

0.21

0.0

1.0

—

45.43

—

Exposure to other and unspecified forces of nature

0.00

0.21

0.0

1.0

—

41.90

—

Lower leg

0.00

0.21

0.0

1.1

—

42.83

—

Inhalation and ingestion of other objects causing obstruction of respiratory tract

0.00

0.21

0.0

1.0

—

44.17

—

0.00

0.21

0.0

1.1

—

36.60

—

Assault by other specified means

0.00

0.21

0.0

1.0

—

32.86

—

Mesial bite

0.00

0.21

0.0

1.1

—

37.14

—

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

0.00

0.21

0.0

1.0

—

30.14

—

Other/unspecified rheumatoid arthritis

304

0.89

0.21

1.0

30.79

46.26

ng/l

1.86

196

Rheumatoid lung disease

0.00

0.21

0.0

1.1

—

39.04

—

Left side

0.00

0.21

0.0

1.0

—

29.63

—

Malignant neoplasm of bone and articular cartilage of limbs

0.00

0.21

0.0

1.0

—

44.17

—

0.00

0.21

0.0

1.1

—

41.88

—

Carcinoma in situ of endometrium

0.00

0.21

0.0

1.1

—

29.13

—

ILD and respiratory illness in diseases classified elsewhere

0.00

0.21

0.0

1.1

—

41.88

—

Blindness or visual impairment, binocular

0.00

0.21

0.0

1.1

—

41.00

—

Sequelae of burns, corrosions and frostbite

0.00

0.21

0.0

1.0

—

41.12

—

Hydrocephalus in other diseases

0.00

0.21

0.0

1.0

—

42.50

—

Benign neoplasm: Retina

0.00

0.21

0.0

1.0

—

45.43

—

Burn and corrosion, body region unspecified

0.00

0.21

0.0

1.0

—

33.50

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

0.00

0.21

0.0

1.1

—

36.33

—

Drug-induced systemic lupus erythematosus

0.00

0.21

0.0

1.1

—

39.43

—

Acute inflammation of orbit

0.00

0.21

0.0

1.0

—

34.40

—

Benign neoplasm: Bone and articular cartilage, unspecified

0.00

0.21

0.0

1.1

—

41.13

—

Dacryoadenitis

0.00

0.21

0.0

1.1

—

44.00

—

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

0.00

0.21

0.0

1.1

—

31.50

—

Other specified/unspecified soft tissue disorders

1.24

0.21

1.0

24.50

46.15

ng/l

—

Procreative management

485

1.08

0.20

1.0

34.40

42.16

ng/l

1.14

346

Obesity due to excess calories

115

1091

1.05

0.20

1.0

30.85

40.83

ng/l

4.49

770

Endometriosis ASRM stages 1,2

287

1.12

0.20

1.0

45.60

44.60

ng/l

0.03

204

Reactive arthropathies

198

0.86

0.20

1.0

46.67

47.53

ng/l

0.03

137

Macular hole

145

1.17

0.20

1.0

49.45

46.21

ng/l

0.10

Striking against or struck by other objects

653

1.07

0.20

1.0

38.03

40.39

ng/l

0.29

452

Coxarthrosis [arthrosis of hip](FG)

194

1348

1.04

0.20

1.0

38.55

44.36

ng/l

1.14

128

940

Foreign body on external eye

345

0.90

0.20

1.0

37.85

39.97

ng/l

0.15

245

Lymphoid leukaemia

123

0.81

0.20

1.2

1.0

39.80

45.61

ng/l

—

Carcinoma in situ of endometrium

0.00

0.20

0.0

1.0

—

30.75

—

Typhoid and paratyphoid fevers

0.00

0.20

0.0

1.1

—

36.86

—

Dermatopolymyositis, unspecified

0.00

0.20

0.0

1.1

—

42.50

—

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

0.00

0.20

0.0

1.1

—

32.22

—

Malignant neoplasm of penis, excluding all cancers (controls excluding all cancers)

0.00

0.20

0.0

1.0

—

29.70

—

Reiter disease

0.00

0.20

0.0

1.0

—

39.61

—

Deformity of finger(s)

0.00

0.20

0.0

1.1

—

34.44

—

Valgus deformity, not elsewhere classified

0.00

0.20

0.0

1.1

—

40.57

—

Recurrent and persistent haematuria

0.00

0.20

0.0

1.0

—

36.75

—

Congenital musculoskeletal deformities of head, face, spine and chest

0.00

0.20

0.0

1.0

—

44.63

—

Excessive, frequent and irregular menstruation

449

1.07

0.20

1.0

40.05

44.35

ng/l

0.48

313

Benign neoplasm: Parotid gland

187

0.85

0.20

1.1

1.0

55.80

45.73

ng/l

—

117

Benign neoplasm: Ascending colon

345

1.10

0.20

1.0

52.33

45.02

ng/l

0.18

229

Chronic sinusitis

117

1111

1.05

0.20

1.0

40.71

42.49

ng/l

0.18

774

Other condition

278

1.12

0.20

1.0

48.13

45.52

ng/l

0.13

187

Other and unspecified anaemias

101

1032

0.95

0.20

1.0

42.07

43.53

ng/l

0.15

680

Asthma, unspecified (mode), excluding more controls

155

1164

1.05

0.20

1.0

50.75

42.27

ng/l

0.29

110

809

Other disorders of iris and ciliary body

1.23

0.20

1.0

32.83

40.60

ng/l

—

Hypertrophy of breast

326

1.10

0.20

1.0

40.99

41.95

ng/l

0.04

233

Acne

1.22

0.20

1.2

1.0

22.67

27.05

ng/l

—

Diabetic retinopathy, strict definition

303

1.10

0.20

1.0

35.37

37.09

ng/l

0.13

208

Pathological resorption of teeth

1.20

0.19

1.2

1.0

57.33

43.20

ng/l

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

1.20

0.19

1.0

43.00

36.11

ng/l

—

Zoster [herpes zoster]

413

1.09

0.19

1.1

1.0

33.50

44.84

ng/l

1.58

274

Dental caries

591

1.07

0.19

1.0

45.14

41.74

ng/l

0.27

400

Benign neoplasm: Rectum

539

1.08

0.19

1.0

43.44

46.58

ng/l

0.29

349

Asthma/COPD (KELA code 203)

276

1884

1.03

0.19

1.0

48.26

41.22

ng/l

0.44

187

1319

Bacterial intestinal infections, IBD co-morbidities

404

1.09

0.19

1.0

41.63

44.43

ng/l

0.22

263

Open wound of forearm

154

0.84

0.19

1.0

37.57

41.91

ng/l

—

Septicaemia

109

996

1.05

0.19

1.0

38.41

43.65

ng/l

1.00

669

Polyp of the female genital tract

447

0.94

0.19

1.0

34.98

44.34

ng/l

1.60

312

Macular pucker

426

0.91

0.18

1.0

36.81

44.20

ng/l

0.80

269

Leiomyoma of uterus

119

704

0.95

0.18

1.0

39.15

47.24

ng/l

0.83

494

Oral lichen ruber planus wide, hypothyreosis or thyroxin

128

1.17

0.18

1.1

1.0

36.11

47.92

ng/l

—

Calcific tendinitis of shoulder

128

1.17

0.18

1.0

37.48

46.21

ng/l

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

289

2011

1.03

0.18

1.0

42.13

41.73

ng/l

0.06

218

1391

Neoplasms

204

1133

0.96

0.18

1.0

39.55

40.68

ng/l

0.15

142

783

Lichen sclerosus et atrophicus

223

1.12

0.18

1.0

42.15

45.41

ng/l

0.09

149

Benign neoplasm: Transverse colon

271

1.11

0.18

1.0

60.92

45.94

ng/l

0.37

179

Retinal vascular occlusion

271

1.11

0.18

1.0

31.52

43.85

ng/l

1.64

165

Bacterial pneumonia, not elsewhere classified

876

0.95

0.17

1.1

1.0

30.10

43.57

ng/l

6.52

598

Other disorders of skin and subcutaneous tissue

199

1761

1.04

0.17

1.0

40.61

43.05

ng/l

0.36

129

1214

Other diseases of the digestive system

795

1.06

0.17

1.0

35.21

44.06

ng/l

1.34

527

Other embolism and thrombosis

310

1.10

0.17

1.1

1.0

41.05

43.94

ng/l

0.21

209

Benign lipomatous neoplasm of other sites/unspecified

226

0.88

0.17

1.0

36.19

48.04

ng/l

1.25

144

Nonalcoholic fatty liver disease

205

0.88

0.17

1.0

30.83

44.79

ng/l

0.68

133

HSIL lesion of the cervix uteri, vagina or vulva

226

0.88

0.17

1.1

1.0

32.50

46.12

ng/l

1.47

163

Benign neoplasm: Tongue

1.11

0.17

1.1

1.0

14.71

49.43

ng/l

—

Perforation of tympanic membrane

205

1.12

0.17

1.0

39.68

45.42

ng/l

0.36

128

Squamous cell neoplasms and carcinomas of the skin

257

0.89

0.17

1.0

29.78

46.45

ng/l

2.54

154

Unspecified acute lower respiratory infection

301

1.10

0.17

1.0

35.66

43.32

ng/l

0.58

208

Other viral diseases, not elsewhere classified

320

1.09

0.16

1.0

37.24

43.89

ng/l

0.50

217

Lichen ruber planus, wide definition including periferal and oral lichen planus

544

1.07

0.16

1.0

40.22

43.99

ng/l

0.33

379

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

162

1672

0.96

0.16

1.0

38.41

43.14

ng/l

0.98

116

1136

Other hearing loss

637

0.94

0.16

1.1

1.0

40.57

45.68

ng/l

0.57

415

Certain disorders involving the immune mechanism

457

1.07

0.16

1.0

40.00

43.89

ng/l

0.35

317

Carcinoma in situ of breast, intraductal

214

0.89

0.15

1.0

51.07

50.83

ng/l

0.01

148

Benign leiomyoma with endometriosis

370

1.08

0.15

1.0

45.08

46.86

ng/l

0.07

252

Oral corticosteroids

320

1888

1.03

0.15

1.0

46.92

40.76

ng/l

0.45

218

1327

Other disorders of adrenal gland

0.78

0.15

1.0

42.83

43.85

ng/l

—

Diseases of the respiratory system

214

1039

1.03

0.15

1.0

44.85

43.40

ng/l

0.16

144

728

Cholecystitis

328

0.91

0.15

1.0

41.75

44.20

ng/l

0.16

220

Asthma-related infections

144

1365

1.04

0.15

1.0

54.44

41.62

ng/l

0.38

926

Asthma, hospital admission 2, infections

144

1365

1.04

0.15

1.0

54.44

41.62

ng/l

0.38

926

Obesity and other hyperalimentation

149

1528

0.96

0.15

1.0

32.26

42.32

ng/l

3.82

108

1082

Asthma, unspecified (mode)

157

1201

1.04

0.15

1.0

51.45

42.19

ng/l

0.33

111

832

Obesity related asthma

868

1.05

0.15

1.0

40.15

41.92

ng/l

0.16

592

Lichen planus

332

1.08

0.15

1.1

1.0

42.58

45.34

ng/l

0.15

221

Other disorders of patella

369

0.92

0.15

1.0

55.64

42.71

ng/l

0.69

264

Pre-eclampsia or poor fetal growth

440

0.93

0.15

1.0

42.70

41.97

ng/l

0.04

316

GI-bleeding

790

1.05

0.15

1.0

31.06

44.25

ng/l

3.91

520

Benign neoplasm of mouth and pharynx

255

1.10

0.15

1.1

1.0

25.10

44.58

ng/l

4.98

164

Chronic nephritic syndrome

1.10

0.15

1.2

1.0

53.62

40.94

ng/l

—

Diabetes mellitus in pregnancy

179

0.91

0.14

1.0

32.64

41.63

ng/l

0.90

139

Vitreous haemorrhage

244

0.90

0.14

1.0

40.71

43.37

ng/l

0.09

161

Embedded and impacted teeth

181

0.89

0.14

1.0

29.53

40.43

ng/l

1.27

117

Primary coxarthrosis, bilateral

809

0.95

0.14

1.0

37.41

44.12

ng/l

1.10

533

Effects of foreign body entering through natural orifice

547

1.06

0.14

1.0

39.30

40.99

ng/l

0.16

385

Ulcerative colitis, NAS

285

0.91

0.14

1.0

36.00

47.09

ng/l

1.14

198

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

181

0.88

0.14

1.0

35.14

51.02

ng/l

0.63

117

Disorders of gallbladder, biliary tract and pancreas

297

1959

0.98

0.14

1.0

47.29

41.04

ng/l

0.40

193

1380

Benign neoplasm of bone and articular cartilage

160

0.87

0.14

1.0

17.61

42.21

ng/l

—

Bacterial pneumoniae

101

932

0.96

0.14

1.0

30.30

43.74

ng/l

6.96

636

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

303

1927

1.02

0.14

1.0

42.27

41.81

ng/l

0.07

201

1365

Vasomotor rhinitis (mode)

160

1.13

0.14

1.0

43.08

46.17

ng/l

0.16

101

Carcinoma in situ of breast, intraductal

212

0.90

0.14

1.0

51.07

49.87

ng/l

0.05

147

Salpingitis and oophoritis

429

0.93

0.14

1.1

1.0

89.74

43.81

ng/l

0.38

303

Diabetic nephropathy, excluding more controls

246

1.09

0.13

1.0

46.94

36.79

ng/l

0.82

167

Chronic pancreatitis

336

0.92

0.13

1.0

28.02

44.13

ng/l

2.98

239

Other shoulder lesions

189

1.11

0.13

1.0

27.37

46.71

ng/l

3.35

126

Orchitis and epididymitis

189

1.11

0.13

1.0

35.82

42.56

ng/l

0.70

118

Candidiasis

284

0.92

0.13

1.0

47.28

45.16

ng/l

0.11

183

Other and unspecified disorders of vitreous body

134

1288

1.04

0.13

1.0

48.03

43.45

ng/l

0.53

894

Benign neoplasm: Skin of eyelid, including canthus

383

1.07

0.13

1.1

1.0

45.89

44.05

ng/l

0.09

254

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

315

1.08

0.13

1.0

36.65

45.08

ng/l

0.99

220

5-aminosalicylic acid

461

1.06

0.13

1.0

36.92

43.48

ng/l

0.60

327

Coronary atherosclerosis

241

1515

1.03

0.13

1.0

40.97

43.35

ng/l

0.30

156

1068

Vestibular neuronitis

228

1.10

0.13

1.0

41.67

46.19

ng/l

0.17

146

Benign neoplasm of ovary

479

0.94

0.13

1.0

79.40

46.78

ng/l

0.34

323

Nutritional anaemias

117

1179

0.97

0.12

1.0

42.61

43.13

ng/l

0.05

782

Persons encountering health services in circumstances related to reproduction

141

987

0.97

0.12

1.0

39.81

42.23

ng/l

0.25

103

733

Nontoxic multinodular goitre

509

0.94

0.12

1.0

44.97

46.02

ng/l

0.04

347

Glomerular diseases

427

0.94

0.12

1.1

1.0

48.23

44.07

ng/l

0.24

291

Disorders of optic nerve and visual pathways

171

1.11

0.12

1.0

40.75

45.52

ng/l

0.23

105

Postprocedural endocrine and metabolic disorders, not elsewhere classified

229

1.09

0.12

1.0

38.67

48.49

ng/l

0.58

151

Obesity

149

1520

0.97

0.12

1.0

32.26

42.36

ng/l

3.83

108

1077

Disorders of muscles

210

0.90

0.12

1.0

37.91

45.62

ng/l

0.48

143

Infective dermatitis

272

0.92

0.12

1.0

40.71

44.39

ng/l

0.16

182

Inflammatory bowel disease treatment related agents

339

1888

1.02

0.12

1.0

45.32

40.76

ng/l

0.34

239

1327

Pregnancy with abortive outcome

148

798

0.97

0.12

1.0

49.09

44.19

ng/l

0.55

101

566

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

116

0.86

0.12

1.0

44.20

49.57

ng/l

—

Diffuse large B-cell lymphoma, helper endpoint

116

0.86

0.12

1.0

44.20

49.57

ng/l

—

Postmenopausal atrophic vaginitis

435

0.95

0.11

1.0

43.06

44.77

ng/l

0.14

307

Retained placenta and membranes, without haemorrhage

230

0.91

0.11

1.1

1.0

145.66

45.37

ng/l

0.55

163

Acute upper respiratory infections

295

1885

0.98

0.11

1.0

36.50

42.93

ng/l

2.13

211

1307

Other obstetric conditions, not elsewhere classified

105

1.11

0.11

1.0

37.50

36.31

ng/l

0.04

Benign leiomyoma with endometriosis

425

0.94

0.11

1.0

45.08

46.74

ng/l

0.06

277

Tuberculosis, IBD comorbidity

153

1.11

0.11

1.1

1.0

25.30

43.92

ng/l

—

Retinal vascular disorders

279

1.08

0.11

1.0

31.52

43.51

ng/l

1.59

169

Acute upper respiratory infections of multiple and unspecified sites

181

1390

0.98

0.11

1.0

34.45

43.44

ng/l

2.74

130

969

Postmenopausal bleeding

438

1.04

0.11

1.0

39.79

44.67

ng/l

0.53

308

All dysplastic lesions of the cervix uteri, vagina or vulva

391

0.94

0.11

1.0

29.68

41.86

ng/l

2.30

283

Radial styloid tenosynovitis [de Quervain]

1.16

0.11

1.0

23.00

46.39

ng/l

—

Other disorders of eyelid

126

1254

0.97

0.11

1.0

36.74

45.10

ng/l

1.61

849

Thyrotoxicosis

567

0.95

0.11

1.0

35.46

44.52

ng/l

1.23

385

Benign neoplasm: Caecum

301

0.93

0.10

1.1

1.0

63.97

48.31

ng/l

0.27

186

Correction of physiology of bite - demanding therapy visit

115

1.13

0.10

1.1

1.0

42.17

44.36

ng/l

—

Other abnormal uterine and vaginal bleeding

397

0.95

0.10

1.0

38.09

45.48

ng/l

0.79

275

Acute appendicitis, no complications

135

1384

0.97

0.10

1.0

36.69

39.32

ng/l

0.51

101

982

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

321

0.93

0.10

1.0

40.70

45.26

ng/l

0.28

212

Secondary uncertain malignant neoplasm

300

0.93

0.10

1.0

40.10

45.59

ng/l

0.35

196

Other/unspecified synovitis and tenosynovitis

261

1.07

0.10

1.0

42.64

45.80

ng/l

0.14

178

Hallux rigidus

398

1.06

0.10

1.0

49.56

46.15

ng/l

0.20

271

Other diseases of pancreas

193

1.09

0.10

1.0

31.21

44.77

ng/l

1.20

130

Systemic sclerosis

1.11

0.10

1.0

57.40

51.58

ng/l

—

Suggestive for eosinophilic asthma

238

0.92

0.09

1.0

48.93

44.78

ng/l

0.19

155

Benign neoplasm: Vulva

1.09

0.09

1.0

76.80

61.47

ng/l

—

Systemic sclerosis (FG)

1.09

0.09

1.0

57.40

61.66

ng/l

—

Sulfasalazine

772

1.04

0.09

1.0

41.31

43.49

ng/l

0.17

540

Nontoxic goitre/thyroid nodule

778

0.96

0.09

1.0

43.73

42.91

ng/l

0.05

527

Degeneration of macula and posterior pole

131

1109

0.97

0.09

1.0

43.18

43.68

ng/l

0.05

715

Other specific arthropathies, wide

1.06

0.09

1.0

34.40

50.94

ng/l

—

Acute pancreatitis (for exclusion)

513

0.95

0.09

1.0

45.78

42.54

ng/l

0.26

349

Acute pancreatitis

513

0.95

0.09

1.0

45.78

43.40

ng/l

0.18

355

Dyspnoea

263

1979

1.02

0.09

1.0

36.14

42.60

ng/l

1.82

179

1386

Other disorders of the genitourinary system

311

1.06

0.09

1.0

51.12

48.20

ng/l

0.13

207

Other disorders of kidney and ureter

311

1.06

0.09

1.0

35.74

44.02

ng/l

0.76

202

Autoimmune diseases related-to ILD

229

2051

0.98

0.09

1.0

36.49

42.29

ng/l

1.46

156

1444

Unspecified jaundice

1.13

0.09

1.0

44.17

43.61

ng/l

—

Menorrhagia

449

1.03

0.09

1.0

37.17

44.35

ng/l

1.26

313

Injuries involving multiple body regions

1.11

0.09

1.0

29.17

44.73

ng/l

—

Endometriosis of ovary

328

0.94

0.08

1.0

47.59

44.65

ng/l

0.13

229

Diseases of salivary glands

461

0.95

0.08

1.0

35.61

42.74

ng/l

1.20

319

Dislocation, sprain and strain of joints and ligaments of knee

152

1443

0.98

0.08

1.0

34.12

42.60

ng/l

1.88

110

1029

Other and unspecified disease of Bartholin gland

1.03

0.08

1.0

26.50

55.04

ng/l

—

Cholesteatoma of middle ear

113

0.88

0.08

1.1

1.0

25.40

45.49

ng/l

—

Adverse effects, not elsewhere classified

371

1.05

0.08

1.1

1.0

47.87

45.23

ng/l

0.13

256

Other and unspecified rosacea

185

1.08

0.08

1.0

57.55

44.83

ng/l

0.52

118

Erosion of teeth, including avohilmo

368

1.05

0.08

1.0

89.26

44.07

ng/l

0.50

266

Viral infections characterized by skin and mucous membrane lesions

966

0.97

0.08

1.1

1.0

32.67

42.47

ng/l

2.47

658

Coxarthrosis, primary

185

1636

0.98

0.08

1.0

39.01

43.75

ng/l

0.88

117

1110

Ulcerative colitis (strict definition, all Crohn cases excluded)

283

1.06

0.08

1.0

36.45

46.16

ng/l

1.07

191

Contraceptive management

694

0.97

0.08

1.0

42.00

41.73

ng/l

0.02

530

Other secondary coxarthrosis

1.05

0.08

1.0

23.71

44.05

ng/l

—

Other specified and unspecified disorders of eye and adnexa

1.03

0.07

1.0

54.71

44.32

ng/l

—

Benign neoplasm: Pancreas

0.83

0.07

1.0

25.33

57.22

ng/l

—

Fracture of foot, except ankle

490

1.04

0.07

1.1

1.0

40.70

42.65

ng/l

0.12

350

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

176

1.08

0.07

1.1

1.0

36.31

47.57

ng/l

0.83

111

Ulcerative colitis (strict definition, require KELA)

323

1.05

0.07

1.0

36.65

44.77

ng/l

0.95

226

Vascular disorders of the intestines

137

1.09

0.07

1.0

26.75

44.63

ng/l

—

Atrial fibrillation and flutter

104

662

1.03

0.07

1.0

42.74

44.51

ng/l

0.17

497

Tuberculosis, wide

157

1.08

0.07

1.1

1.0

25.30

45.44

ng/l

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

163

0.92

0.07

1.0

32.07

47.81

ng/l

2.14

Benign lipomatous neoplasm of other sites/unspecified

214

0.93

0.07

1.0

36.19

45.59

ng/l

0.91

135

Symptoms and signs involving the skin and subcutaneous tissue

181

1831

0.98

0.06

1.0

49.25

41.49

ng/l

0.32

129

1266

Gestational [pregnancy-induced] hypertension

343

1.05

0.06

1.1

1.0

36.81

42.61

ng/l

0.48

249

Preparation and fitting of bite rail to mouth

275

0.95

0.06

1.0

43.80

42.94

ng/l

0.04

190

Acute suppurative otitis media

275

1.05

0.06

1.1

1.0

32.71

43.41

ng/l

1.58

174

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

153

1557

0.98

0.06

1.0

38.46

42.89

ng/l

0.83

109

1063

Hernia of abdominal wall, postoperative

434

1.04

0.06

1.0

37.95

44.51

ng/l

0.55

337

Retinal breaks without detachment

444

1.04

0.06

1.0

50.59

43.15

ng/l

0.56

301

Pre-eclampsia or eclampsia

375

0.96

0.05

1.1

1.0

46.10

43.35

ng/l

0.15

270

Scoliosis

129

1.09

0.05

1.0

40.51

50.58

ng/l

—

Umbilical hernia

688

0.97

0.05

1.0

48.56

41.39

ng/l

0.34

490

Seborrhoeic keratosis

597

0.97

0.05

1.0

38.38

44.94

ng/l

0.62

403

Hypokalaemia

257

1.05

0.05

1.0

31.72

47.35

ng/l

0.96

167

Other maternal disorders predominantly related to pregnancy

125

800

0.98

0.05

1.0

38.65

44.53

ng/l

0.86

590

Other and unspecified local infections of skin and subcutaneous tissue

202

0.94

0.05

1.0

38.42

47.04

ng/l

0.53

128

Ptosis of eyelid

267

1.05

0.05

1.1

1.0

21.65

45.32

ng/l

8.16

174

Long labour

265

0.96

0.05

1.0

61.33

39.76

ng/l

1.36

202

Ethmoidectomy

303

0.96

0.05

1.0

42.77

45.96

ng/l

0.18

207

914

1.02

0.05

1.0

39.92

42.25

ng/l

0.18

625

Benign neoplasm: Skin of eyelid, including canthus

424

0.97

0.05

1.1

1.0

45.89

48.01

ng/l

0.10

277

Follicular cysts of skin and subcutaneous tissue

424

0.97

0.05

1.0

39.26

42.39

ng/l

0.26

296

Cutaneous abscess, furuncle and carbuncle

545

1.03

0.04

1.0

31.97

41.97

ng/l

1.50

381

Other specified/unspecified arthritis

686

0.98

0.04

1.0

40.51

42.99

ng/l

0.23

465

Other complications of surgical and medical care, not elsewhere classified

209

1.05

0.04

1.0

34.13

44.61

ng/l

0.87

132

Other disorders of teeth and supporting structures

534

0.97

0.04

1.0

41.76

42.45

ng/l

0.05

361

Other diseases of stomach and duodenum

150

1.07

0.04

1.0

54.92

40.77

ng/l

0.46

Spontaneous abortion

685

0.98

0.04

1.0

37.37

43.84

ng/l

0.80

503

Deep bite

140

0.94

0.04

1.0

35.90

44.35

ng/l

—

Leiomyoma of uterus

158

910

0.99

0.04

1.0

40.96

45.20

ng/l

0.46

120

642

Blepharochalasis

825

1.02

0.04

1.0

40.81

44.79

ng/l

0.45

547

Glomerulonephritis

220

0.95

0.03

1.1

1.0

44.84

44.13

ng/l

0.02

143

Superficial injury of shoulder and upper arm

220

1.05

0.03

1.0

35.81

43.44

ng/l

0.39

146

Familial hypercholesterolemia, with ischemic heart disease

250

0.96

0.03

1.0

38.25

43.47

ng/l

0.36

161

Benign neoplasm: Ascending colon

391

0.97

0.03

1.0

52.33

47.01

ng/l

0.13

244

Acute sinusitis

117

1104

0.99

0.03

1.0

34.90

41.35

ng/l

1.25

771

Other blood glucose lowering drugs, excl. Insulins

469

1.02

0.03

1.0

40.89

45.24

ng/l

0.28

311

Bronchiectasis

209

0.96

0.03

1.0

38.49

46.34

ng/l

0.55

127

Other local infections of skin and subcutaneous tissue

219

0.96

0.03

1.0

38.42

46.42

ng/l

0.49

143

Artificial joint operation, meniscal resection

297

1963

1.01

0.03

1.0

44.35

41.64

ng/l

0.49

201

1381

Intestinal stricture

792

0.98

0.03

1.0

33.94

43.97

ng/l

2.13

529

Melanocytic naevi of other and unspecified parts of face

118

0.93

0.02

1.0

51.20

50.63

ng/l

—

Foreign body or object entering through skin

118

0.93

0.02

1.1

1.0

29.91

40.57

ng/l

0.91

Medical abortion

145

796

0.99

0.02

1.0

49.41

44.19

ng/l

0.53

102

566

Benign neoplasm: Caecum

271

1.03

0.02

1.1

1.0

63.98

46.05

ng/l

0.32

173

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

648

1.02

0.02

1.0

35.00

40.31

ng/l

0.48

466

Benign neoplasm of mouth and pharynx

289

0.97

0.02

1.1

1.0

25.10

47.17

ng/l

6.05

186

Angina pectoris

208

1394

1.01

0.02

1.0

37.54

43.87

ng/l

1.38

140

969

Atrophic disorders of skin

309

0.97

0.02

1.0

44.24

45.75

ng/l

0.05

207

Suppurative and unspecified otitis media

452

0.98

0.02

1.0

40.53

41.85

ng/l

0.11

308

Other diseases of blood and blood-forming organs

168

0.95

0.02

1.0

43.55

44.82

ng/l

0.04

101

Sequelae of external causes of morbidity and mortality

610

0.98

0.02

1.0

32.29

44.77

ng/l

2.83

412

Unspecified kidney failure

208

0.96

0.02

1.0

33.19

43.49

ng/l

0.76

126

Asthma and opportunity respiratory infection

107

0.93

0.02

1.0

46.20

46.83

ng/l

—

LSIL lesion of the cervix uteri

123

1.06

0.01

1.0

34.99

47.08

ng/l

—

False labour

196

1.03

0.01

1.0

29.41

42.34

ng/l

1.52

155

Artificial joint re-operation

173

1.04

0.01

1.1

1.0

43.92

46.89

ng/l

0.18

104

Sequelae with surgical and medical care as external cause

492

1.02

0.01

1.0

31.40

44.31

ng/l

2.94

329

Benign neoplasm of other and ill-defined parts of digestive system

508

0.98

0.01

1.0

43.80

46.44

ng/l

0.15

331

Other or unspecified ileus, impaction or obstruction

452

1.02

0.01

1.0

35.44

45.09

ng/l

1.15

304

Glaucoma, exfoliation

237

0.97

0.01

1.0

39.08

43.57

ng/l

0.34

146

Diseases of peritoneum

237

0.97

0.01

1.0

35.08

46.78

ng/l

0.87

151

Benign neoplasm: Skin of other and unspecified parts of face

247

0.97

0.01

1.0

36.72

45.05

ng/l

0.60

162

339

1796

1.00

0.01

1.0

36.96

42.39

ng/l

2.03

233

1253

Localized swelling, mass and lump of skin and subcutaneous tissue

787

0.99

0.01

1.0

38.60

42.41

ng/l

0.41

534

Unspecified/other endometriosis

1.06

0.01

1.0

38.10

52.61

ng/l

—

Injury of other and unspecified intrathoracic organs

136

0.96

0.00

1.0

32.25

41.41

ng/l

—

Presence of other functional implants

186

1322

1.00

0.00

1.0

40.91

44.63

ng/l

0.51

129

883

Fall on and from ladder

194

1.03

0.00

1.1

1.0

27.08

41.24

ng/l

1.05

127

Chondropathies

324

1.02

0.00

1.0

35.85

45.45

ng/l

1.06

227

Unspecified lump in breast

334

1.02

0.00

1.0

36.26

44.78

ng/l

0.90

233

Methotrexate

374

1.02

0.00

1.0

45.71

45.58

ng/l

0.01

264

Other diseases of lip and oral mucosa

396

0.98

0.00

1.1

1.0

42.68

43.85

ng/l

0.07

273

Migraine, single triptan purchase ok & required. ICD-code if available is included

194

1317

1.00

0.00

1.0

37.73

42.33

ng/l

0.82

136

954

Triptan medication for migraine, single purchase ok

194

1317

1.00

0.00

1.0

37.73

42.33

ng/l

0.82

136

954

TMD related operations

337

1.01

0.00

1.0

39.72

45.14

ng/l

0.40

233

Pacemaker

831

0.99

0.00

1.0

42.32

43.77

ng/l

0.13

525

Benign neoplasm: Rectum, anus and anal canal

599

1.00

0.00

1.0

51.17

45.59

ng/l

0.27

389

Presbycusis

264

1.02

0.00

1.1

1.0

31.32

47.09

ng/l

2.97

158

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.02

0.00

1.0

39.70

37.80

ng/l

—

Paroxysmal tachycardia

491

1.00

0.00

1.1

1.0

38.96

45.10

ng/l

0.86

355

Sequelae of injuries of lower limb

192

0.99

0.00

1.1

1.0

37.08

46.17

ng/l

0.57

123

Otosclerosis

185

0.97

0.00

1.0

61.91

45.25

ng/l

0.59

115

Oral leukoplakia and related diseases, including avohilmo

225

0.98

0.00

1.0

39.23

46.63

ng/l

0.42

140

Pedal cyclist injured in other and unspecified transport accidents

225

1.02

0.00

1.0

27.64

44.82

ng/l

2.70

145

Other diseases of hard tissues of teeth

178

1329

1.00

0.00

1.0

48.08

41.07

ng/l

0.30

135

935

Complications of internal orthopaedic prosthetic devices, implants and grafts

605

0.99

0.00

1.0

36.70

44.56

ng/l

1.30

402

Other nutritional deficiencies

161

1576

1.00

0.00

1.0

31.08

42.39

ng/l

5.21

116

1108

Melanocytic naevi of other and unspecified parts of face

106

1.04

0.00

1.0

51.20

46.63

ng/l

—

Other benign neoplasms of skin

981

1.00

0.00

1.1

1.0

43.66

43.40

ng/l

0.02

661

Inflammatory disease of uterus

204

0.98

0.00

1.0

43.91

47.12

ng/l

0.16

141

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

226

1.02

0.00

1.0

45.34

49.38

ng/l

0.18

137

Diabetic nephropathy

314

1.01

0.00

1.0

46.94

34.63

ng/l

1.09

204

FESS (DNB20)

287

1.01

0.00

1.0

42.77

46.34

ng/l

0.20

195

Benign lipomatous neoplasm

859

1.00

0.00

1.0

37.02

42.70

ng/l

0.94

575

Thyrotoxicosis, other and/or unspecified

422

1.00

0.00

1.0

33.74

45.94

ng/l

1.87

295

Other disorders of conjunctiva

349

1.00

0.00

1.0

45.69

42.97

ng/l

0.17

227

Intestinal adhesions without obstruction

196

1.02

0.00

1.0

29.55

46.86

ng/l

1.41

131

Sicca syndrome [Sjögren]

196

1.02

0.00

1.0

36.77

44.32

ng/l

0.42

130

Unspecified abortion

1.02

0.00

1.0

45.40

49.09

ng/l

—

Spontaneous rupture of synovium and tendon

205

1.02

0.00

1.0

58.08

46.70

ng/l

0.47

139

Acute peritonitis

127

1.02

0.00

1.0

29.60

43.68

ng/l

—

Nontoxic single thyroid nodule

167

1.02

0.00

1.0

47.14

47.80

ng/l

0.03

114

Diffuse large B-cell lymphoma

105

0.95

0.00

1.0

44.20

44.99

ng/l

—

Mixed hyperlipidaemia

1.05

0.00

1.0

29.26

48.94

ng/l

—

Duodenal ulcer

250

1.00

0.00

1.0

42.68

44.64

ng/l

0.10

153

Contact with other sharp object(s)

0.98

0.00

1.0

27.33

42.15

ng/l

—

Benign neoplasm: Pancreas

1.00

0.00

1.0

25.33

39.20

ng/l

—

Benign neoplasm: Transverse colon

300

1.00

0.00

1.0

60.92

46.51

ng/l

0.35

189

Dermatographic urticaria

110

1.00

0.00

1.0

45.50

47.25

ng/l

—

Anaemia in chronic diseases classified elsewhere

0.94

0.00

1.0

41.80

39.24

ng/l

—

Hirsutism, drug-induced

0.00

0.0

1.0

—

31.20

—

Crossbite

0.87

0.00

1.0

21.67

46.33

ng/l

—

Benign neoplasm: Lacrimal gland and duct

0.00

0.0

1.0

—

38.20

—

Use of rasagiline

0.91

0.00

1.2

1.0

26.00

45.62

ng/l

—

Ependymoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

47.43

—

Cyst of Bartholin Gland

0.95

0.00

1.3

1.0

50.48

53.86

ng/l

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS